
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            In situ–formed immunotherapeutic hydrogel containing sphingosine-1-phosphate for enhanced lung cancer immunotherapy - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="FF2081DE89B735D31A81DE00425BC843.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="sciadv">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333694/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Science Advances">
<meta name="citation_title" content="In situ–formed immunotherapeutic hydrogel containing sphingosine-1-phosphate for enhanced lung cancer immunotherapy">
<meta name="citation_author" content="Hui Shen">
<meta name="citation_author_institution" content="Department of Thoracic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200086, China.">
<meta name="citation_author_institution" content="Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China.">
<meta name="citation_author" content="Qi Deng">
<meta name="citation_author_institution" content="Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.">
<meta name="citation_author" content="Zhike Chen">
<meta name="citation_author_institution" content="Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China.">
<meta name="citation_author_institution" content="Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.">
<meta name="citation_author" content="Qiang Zhang">
<meta name="citation_author_institution" content="Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China.">
<meta name="citation_author_institution" content="School of Materials Science and Engineering, Tongji University, Shanghai 201804, China.">
<meta name="citation_author" content="Xiao Zhou">
<meta name="citation_author_institution" content="Department of Thoracic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200086, China.">
<meta name="citation_author" content="Qian Chen">
<meta name="citation_author_institution" content="Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China.">
<meta name="citation_author" content="Jiang Fan">
<meta name="citation_author_institution" content="Department of Thoracic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200086, China.">
<meta name="citation_publication_date" content="2025 Aug 8">
<meta name="citation_volume" content="11">
<meta name="citation_issue" content="32">
<meta name="citation_firstpage" content="eadw5001">
<meta name="citation_doi" content="10.1126/sciadv.adw5001">
<meta name="citation_pmid" content="40779634">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333694/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333694/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333694/pdf/sciadv.adw5001.pdf">
<meta name="description" content="Limited infiltration of immune cells within tumors restricts the therapeutic efficiency of immune checkpoint blockades. Herein, we discover that sphingosine-1-phosphate (S1P) is down-regulated in patients with lung cancer who do not respond to ...">
<meta name="og:title" content="In situ–formed immunotherapeutic hydrogel containing sphingosine-1-phosphate for enhanced lung cancer immunotherapy">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Limited infiltration of immune cells within tumors restricts the therapeutic efficiency of immune checkpoint blockades. Herein, we discover that sphingosine-1-phosphate (S1P) is down-regulated in patients with lung cancer who do not respond to ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333694/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12333694">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1126/sciadv.adw5001"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/sciadv.adw5001.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12333694%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12333694/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12333694/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333694/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-sciadv.gif" alt="Science Advances logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Science Advances" title="Link to Science Advances" shape="default" href="http://advances.sciencemag.org/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Sci Adv</button></div>. 2025 Aug 8;11(32):eadw5001. doi: <a href="https://doi.org/10.1126/sciadv.adw5001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1126/sciadv.adw5001</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Sci%20Adv%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sci%20Adv%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Sci%20Adv%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Sci%20Adv%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>In situ–formed immunotherapeutic hydrogel containing sphingosine-1-phosphate for enhanced lung cancer immunotherapy</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shen%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Hui Shen</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Hui Shen</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Thoracic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200086, China.</div>
<div class="p">
<sup><sup>2</sup></sup>Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China.</div>
<div>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Resources, Validation, Visualization, Writing - original draft, Writing - review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shen%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hui Shen</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Deng%20Q%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Qi Deng</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Qi Deng</span></h3>
<div class="p">
<sup><sup>3</sup></sup>Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.</div>
<div>Investigation, Methodology, Visualization</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Deng%20Q%22%5BAuthor%5D" class="usa-link"><span class="name western">Qi Deng</span></a>
</div>
</div>
<sup>3,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Zhike Chen</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Zhike Chen</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China.</div>
<div class="p">
<sup><sup>4</sup></sup>Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.</div>
<div>Data curation, Formal analysis, Investigation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhike Chen</span></a>
</div>
</div>
<sup>2,</sup><sup>4,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Q%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Qiang Zhang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Qiang Zhang</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China.</div>
<div class="p">
<sup><sup>5</sup></sup>School of Materials Science and Engineering, Tongji University, Shanghai 201804, China.</div>
<div>Investigation, Validation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Q%22%5BAuthor%5D" class="usa-link"><span class="name western">Qiang Zhang</span></a>
</div>
</div>
<sup>2,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Xiao Zhou</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Xiao Zhou</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Thoracic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200086, China.</div>
<div>Conceptualization, Investigation, Supervision, Writing - original draft</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiao Zhou</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20Q%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Qian Chen</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Qian Chen</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China.</div>
<div>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing - original draft, Writing - review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20Q%22%5BAuthor%5D" class="usa-link"><span class="name western">Qian Chen</span></a>
</div>
</div>
<sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fan%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Jiang Fan</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Jiang Fan</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Thoracic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200086, China.</div>
<div>Conceptualization, Funding acquisition, Investigation, Supervision, Writing - original draft, Writing - review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fan%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiang Fan</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup><sup>1</sup></sup>Department of Thoracic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200086, China.</div>
<div id="aff2">
<sup><sup>2</sup></sup>Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China.</div>
<div id="aff3">
<sup><sup>3</sup></sup>Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.</div>
<div id="aff4">
<sup><sup>4</sup></sup>Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.</div>
<div id="aff5">
<sup><sup>5</sup></sup>School of Materials Science and Engineering, Tongji University, Shanghai 201804, China.</div>
<div class="author-notes p">
<div class="fn" id="cor1">
<sup>*</sup><p class="display-inline">Corresponding author. Email: <span>13905601531@139.com</span> (X.Z.); <span>chenqian@suda.edu.cn</span> (Q.C.); <span>fan_jiang@sjtu.edu.cn</span> (J.F.)</p>
</div>
<div class="fn" id="afn1">
<sup>†</sup><p class="display-inline">These authors contributed equally to this work.</p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Hui Shen</span></strong>: <span class="role">Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Resources, Validation, Visualization, Writing - original draft, Writing - review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Qi Deng</span></strong>: <span class="role">Investigation, Methodology, Visualization</span>
</div>
<div>
<strong class="contrib"><span class="name western">Zhike Chen</span></strong>: <span class="role">Data curation, Formal analysis, Investigation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Qiang Zhang</span></strong>: <span class="role">Investigation, Validation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Xiao Zhou</span></strong>: <span class="role">Conceptualization, Investigation, Supervision, Writing - original draft</span>
</div>
<div>
<strong class="contrib"><span class="name western">Qian Chen</span></strong>: <span class="role">Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing - original draft, Writing - review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jiang Fan</span></strong>: <span class="role">Conceptualization, Funding acquisition, Investigation, Supervision, Writing - original draft, Writing - review &amp; editing</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Feb 5; Accepted 2025 Jul 3; Collection date 2025 Aug 8.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2025 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).</div>
<p>This is an open-access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by-nc/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution-NonCommercial license</a>, which permits use, distribution, and reproduction in any medium, so long as the resultant use is <strong>not</strong> for commercial advantage and provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12333694  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40779634/" class="usa-link">40779634</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Limited infiltration of immune cells within tumors restricts the therapeutic efficiency of immune checkpoint blockades. Herein, we discover that sphingosine-1-phosphate (S1P) is down-regulated in patients with lung cancer who do not respond to PD-1/PD-L1 therapy. Our findings indicate that S1P gradient enhances the migration and viability of immune cells and promotes the polarization of macrophages toward the M1 phenotype primarily through mitochondrial reactive oxygen species–activated nuclear factor κB and Janus kinase–signal transducers and activators of transcription signaling pathways. To capitalize on these findings, we used a biodegradable sodium alginate hydrogel as a delivery system for the sustained and sequential release of S1P and anti–PD-L1 (αPDL1). In vivo studies demonstrated that S1P-αPDL1@Gel effectively inhibited tumor growth and reduced the recurrence of local tumors after surgery. Additionally, the hydrogel significantly enhanced the infiltration of dendritic cells, M1 macrophages, CD4<sup>+</sup> T cells, and CD8<sup>+</sup> T cells. S1P-αPDL1@Gel holds a promising therapeutic strategy for remodeling the immunosuppressive tumor microenvironment.</p></section><section class="abstract" id="abstract2"><hr class="headless">
<p>Hydrogel containing sphingosine-1-phosphate improves lung cancer immunotherapy for patients resistant to PD-1/PD-L1 therapy.</p></section><section id="sec1"><h2 class="pmc_sec_title">INTRODUCTION</h2>
<p>Lung cancer ranks as the second most common cancer and the primary cause of cancer-related deaths around the world (<a href="#R1" class="usa-link" aria-describedby="R1"><em>1</em></a>). This highly aggressive disease accounted for ~2.2 million diagnosed cases and resulted in 1.8 million deaths in 2020 worldwide (<a href="#R2" class="usa-link" aria-describedby="R2"><em>2</em></a>). Lung cancer can be classified into small cell lung cancer (SCLC) and non-SCLC (NSCLC). Lung adenocarcinoma (LUAD) represents the primary subtype of NSCLC, comprising roughly 60% of all NSCLC cases (<a href="#R3" class="usa-link" aria-describedby="R3"><em>3</em></a>). While chemotherapy, radiotherapy, and epidermal growth factor receptor (EGFR)–targeted therapy have enhanced patient outcomes, these treatments, along with surgery, still face substantial challenges (<a href="#R4" class="usa-link" aria-describedby="R4"><em>4</em></a>). Surgical resection remains the most effective treatment for early stage and selected cases of stage IIIA NSCLC (<a href="#R5" class="usa-link" aria-describedby="R5"><em>5</em></a>). However, it cannot guarantee the complete eradication of tumor cells, and a significant proportion of patients experiences tumor recurrence. Postoperative radiotherapy and chemotherapy are commonly used as adjuvant therapies or as palliative options for patients with advanced stages of tumors (<a href="#R6" class="usa-link" aria-describedby="R6"><em>6</em></a>). However, these treatments are plagued by severe systemic toxicity, limited efficacy, and development of acquired drug resistance, all of which remain unresolved issues (<a href="#R7" class="usa-link" aria-describedby="R7"><em>7</em></a>). Molecularly targeted therapies, such as EGFR tyrosine kinase inhibitor, have shown improved survival outcomes compared to conventional chemoradiotherapy (<a href="#R8" class="usa-link" aria-describedby="R8"><em>8</em></a>). However, only a small subset of patients harbors EGFR gene mutations, limiting the broader applicability of these therapies.</p>
<p>Immunotherapies, especially immune checkpoint inhibitors, have been widely used in clinical practice, offering significant promise for patients with advanced lung cancer (<a href="#R9" class="usa-link" aria-describedby="R9"><em>9</em></a>). However, only a small subset of people exhibits durable responses to these treatments, which is primarily due to the complex tumor immune status (<a href="#R10" class="usa-link" aria-describedby="R10"><em>10</em></a>). The immune status of tumors plays a pivotal role in determining the effectiveness of immunotherapy and can be categorized into three distinct phenotypes: inflamed, immune excluded, and immune desert (<a href="#R11" class="usa-link" aria-describedby="R11"><em>11</em></a>, <a href="#R12" class="usa-link" aria-describedby="R12"><em>12</em></a>). The last two phenotypes are also called “cold” phenotype. Patients with cold tumors, characterized by a weak immune response to tumors, are less likely to benefit from immunotherapy (<a href="#R13" class="usa-link" aria-describedby="R13"><em>13</em></a>). The “immune-excluded” phenotype refers to tumors with a significant presence of T cells within the tumor stroma. However, these T cells are unable to penetrate the stroma and infiltrate the tumor due to a highly suppressive microenvironment (<a href="#R14" class="usa-link" aria-describedby="R14"><em>14</em></a>). In contrast, “desert-type” tumors are characterized by a complete lack of infiltrated immune cells even in the stroma, creating a true “immune desert” where immune activity is virtually absent (<a href="#R15" class="usa-link" aria-describedby="R15"><em>15</em></a>). The lack of immune cells infiltration in desert-type tumors can be related to various mechanisms, such as impaired T cell priming, defects in antigen presentation, low expression levels of major histocompatibility complex I antigens on the surface of cancer cells, and the presence of immune inhibitory molecules like B7-H4 (<a href="#R16" class="usa-link" aria-describedby="R16"><em>16</em></a>, <a href="#R17" class="usa-link" aria-describedby="R17"><em>17</em></a>). These factors collectively contribute to the immune evasion strategies of the tumor, making it challenging to achieve immunotherapeutic responses. The development of immunotherapy based on biomaterials may represent a significant breakthrough in addressing the current challenges (<a href="#R18" class="usa-link" aria-describedby="R18"><em>18</em></a>, <a href="#R19" class="usa-link" aria-describedby="R19"><em>19</em></a>).</p>
<p>Sphingosine-1-phosphate (S1P) is a bioactive lipid that serves as the final product of sphingolipid metabolism (<a href="#R20" class="usa-link" aria-describedby="R20"><em>20</em></a>). It is predominantly found in blood and lymph, where it is produced and secreted by red blood cells (RBCs), endothelial cells, and platelets into the extracellular environment. S1P is generated through the action of sphingosine kinases, primarily sphingosine kinase 1 (SPHK1), from its precursor, ceramide (<a href="#R21" class="usa-link" aria-describedby="R21"><em>21</em></a>). While S1P is present at very low concentrations intracellularly, this is due to the action of the endoplasmic reticulum–resident S1P lysate. Specific tissue-specific transporters, such as spinster homolog 2 (SPNS2), are responsible for exporting S1P into the extracellular space (<a href="#R22" class="usa-link" aria-describedby="R22"><em>22</em></a>). The concentration gradients of S1P across various biological compartments are essential for regulating the fidelity and specificity of several biological processes, including cell survival, innate immunity, and antitumor immune responses (<a href="#R23" class="usa-link" aria-describedby="R23"><em>23</em></a>). S1P exerts its biological effects by binding to its specific receptors, S1P receptors (S1PRs), which are expressed on immune and endothelial cells (<a href="#R24" class="usa-link" aria-describedby="R24"><em>24</em></a>).</p>
<p>Recent evidence has highlighted the crucial role of S1P in the regulation of innate immunity (<a href="#R21" class="usa-link" aria-describedby="R21"><em>21</em></a>). The concentration of S1P in blood is significantly higher than lymphoid tissues. During immune response, S1P acts as a lipid chemoattractant, guiding T lymphocytes from low-S1P lymphoid tissues to the high-S1P circulation system (<a href="#R25" class="usa-link" aria-describedby="R25"><em>25</em></a>). T cells primarily respond to S1P signaling through the S1PR1. Previous studies have shown that S1PR1-knockout T cells failed to exit the thymus and egress into lymph in fetal liver chimeric models (<a href="#R26" class="usa-link" aria-describedby="R26"><em>26</em></a>). Moreover, S1P is essential not only for the circulation of naïve T cell but also for their survival, maturation, and differentiation. Knockdown of S1PR1 expression in T cells results in a 40% decrease in both total and functional mitochondria (<a href="#R27" class="usa-link" aria-describedby="R27"><em>27</em></a>). Moreover, S1P gradients are involved in orchestrating the localization and interferon-γ (IFN-γ) response of natural killer cells (<a href="#R28" class="usa-link" aria-describedby="R28"><em>28</em></a>). Multiple sclerosis (MS) is an autoimmune disorder characterized by demyelination and the excessive activation of immune cells, notably T cells and macrophages. Fingolimod, an S1PR-targeted drug, is used to treat MS by functionally antagonizing S1PR1 (<a href="#R29" class="usa-link" aria-describedby="R29"><em>29</em></a>). While many of the existing studies have focused on inflammatory diseases, the role of S1P signaling in the tumor microenvironment (TME) remains poorly understood (<a href="#R30" class="usa-link" aria-describedby="R30"><em>30</em></a>). A study by Chongsathidkiet <em>et al</em>. (<a href="#R31" class="usa-link" aria-describedby="R31"><em>31</em></a>) demonstrated that glioblastoma tumors exhibit relatively low expression of S1PR1 compared to paired normal tissues. This reduced expression of S1PR1 leads to the sequestration of naïve T cells in the bone marrow, thereby suppressing antitumor immune responses. However, the role of S1P and its receptor S1PR1 in lung cancer remains largely unexplored.</p>
<p>Given the therapeutic effects of fingolimod in MS, we hypothesized that S1P might enhance antitumor immunity by activating immune cells in lung cancer. To investigate this, we conducted the study to investigate the role of S1P signaling in lung cancer and develop an innovative immunotherapeutic strategy. Our results revealed that both S1P levels and its receptor, S1PR1, were notably decreased in individuals with lung cancer compared to those in healthy controls. Notably, patients with higher S1P levels exhibited better response rates to immunotherapy. These clinical data suggest that S1P may serve as a critical signaling molecule in modulating immune response in lung cancer. In vitro experiments further confirmed that S1P could enhance dendritic cell (DC) maturation, promote M1 tumor-associated macrophage (TAM) polarization, and facilitate T cell migration. Mechanistically, we found that S1P increased mitochondrial reactive oxygen species (mtROS) production and mitochondrial biogenesis, activating inflammatory pathways including the nucleotide-binding oligomerization domain (NOD)–like receptor (NLR) family pyrin domain–containing 3 (NLRP3) inflammasome, nuclear factor κB (NF-κB), and Janus kinase–signal transducers and activators of transcription (JAK-STAT). To address the challenge of delivering S1P and establishing a concentration gradient between the tumor and bloodstream, we developed an innovative S1P-containing sodium alginate hydrogel (S1P-αPDL1@Gel) for sustained and sequential release of S1P and anti–programmed death-ligand 1 (αPDL1) within tumors (<a href="#F1" class="usa-link">Fig. 1</a>). This formulation retained S1P for up to 4 days and αPDL1 for up to 8 days, doubling the release duration compared to free drugs. The initially released S1P enhanced immune cell infiltration, while the delayed release of αPDL1 restored T cell and macrophage function. In vivo, S1P-αPDL1@Gel significantly inhibited tumor growth and recurrence, with average tumor volume in treated mice only a quarter of that in the phosphate-buffered saline (PBS) control group. Moreover, three of the six mice treated with S1P-αPDL1@Gel exhibited significantly reduced tumor recurrence (tumor volume &lt; 200 cm<sup>3</sup>). As expected, tumors treated with S1P-αPDL1@Gel exhibited increased apoptosis, reduced cell proliferation, and promoted infiltration of mature DCs, M1 TAMs, and CD4<sup>+</sup> T, CD8<sup>+</sup> T, and IFN-γ<sup>+</sup> T cells. Therefore, the S1P-αPDL1@Gel could effectively remodel the TME through a “two-step” strategy, immune infiltration followed by activation, making it a promising approach for treating cold tumors and as an adjuvant therapy postsurgery.</p>
<figure class="fig xbox font-sm" id="F1"><h3 class="obj_head">Fig. 1. Schematic illustration of the immunomodulatory hydrogel for enhanced lung cancer immunotherapy.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333694_sciadv.adw5001-f1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba3/12333694/4be69ea821d2/sciadv.adw5001-f1.jpg" loading="lazy" height="830" width="731" alt="Fig. 1."></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Clinical findings indicated that elevated plasma S1P levels correlated with a higher immune response to anti–PD-L1 (αPDL1)/PD-1 blockade, suggesting S1P as a unique immunoadjuvant for lung cancer immunotherapy. Inspired by these findings, we developed an in situ–formed immunotherapeutic hydrogel, which realized sustained and sequential release of S1P and αPDL1 within the tumor. The initial release of S1P establishes a concentration gradient between the tumor and bloodstream, enhancing immune cell infiltration via mitochondrial ROS production, mitochondrial biogenesis, and activation of inflammatory pathways, including the NLRP3 inflammasome, NF-κB, and JAK-STAT. Subsequently, the released αPDL1 dismantles the tumor’s immune evasion mechanisms, restoring the function of T cells and macrophages.</p></figcaption></figure></section><section id="sec2"><h2 class="pmc_sec_title">RESULTS</h2>
<section id="sec3"><h3 class="pmc_sec_title">S1P expression among patients with NSCLC</h3>
<p>Given that S1PR1 and SPNS2 are crucial for the reception and transport of S1P signals (<a href="#R32" class="usa-link" aria-describedby="R32"><em>32</em></a>), we explored their expression using The Cancer Genome Atlas (TCGA) Program dataset. Our analysis revealed that both the S1PR1 and SPNS2 were significantly down-regulated in tumor tissues compared to those in matched normal tissues (<a href="#F2" class="usa-link">Fig. 2A</a>). Moreover, SPHK1, a kinase responsible for S1P production (<a href="#R33" class="usa-link" aria-describedby="R33"><em>33</em></a>), also exhibited lower expression levels in LUAD tissues compared to those in matched normal tissues (fig. S1). Survival analysis using Kaplan-Meier plotter, a platform providing the survival data from TCGA (<a href="#R34" class="usa-link" aria-describedby="R34"><em>34</em></a>), indicated that the mRNA expressions of S1PR1 and SPNS2 were significantly associated with the survival of patients with lung cancer, with hazard ratio (95% confidence interval) of 0.74 (0.66 to 0.84) and 0.78 (0.67 to 0.9), respectively (<a href="#F2" class="usa-link">Fig. 2B</a>). These findings suggest that low expression levels of S1PR1 and SPNS2 are associated with worse prognosis in the patients with lung cancer. Given the critical role of S1P signaling in modulating immune responses, we further explored the immunological implications of these genes. Using Timer 2.0 dataset, which integrates tumor immune infiltration data (<a href="#R35" class="usa-link" aria-describedby="R35"><em>35</em></a>), we found a positive correlation between the level of S1PR1 and the activation of several immune cell types, including CD8<sup>+</sup> T cells, CD4<sup>+</sup> T cells, macrophages, and myeloid DCs, but a negative correlation between S1PR1 and myeloid-derived suppressor cells (MDSCs) in both LUAD and lung squamous cell carcinoma (<a href="#F2" class="usa-link">Fig. 2C</a> and fig. S2). Similarly, a corresponding analysis for SPNS2 revealed comparable correlations with immune cell activation and MDSC infiltration (figs. S3 and S4).</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Fig. 2. The critical role of S1P signaling in tumor immune microenvironment of NSCLC.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333694_sciadv.adw5001-f2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba3/12333694/cb21b0e33b00/sciadv.adw5001-f2.jpg" loading="lazy" height="1015" width="766" alt="Fig. 2."></a></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) The expression levels of S1PR1 and SPNS2 in tumor tissues and matched normal tissues from The Cancer Genome Atlas (TCGA) data are presented. (<strong>B</strong>) The prognostic significance of S1PR1 and SPNS2 in NSCLC based on TCGA data. (<strong>C</strong>) S1PR1 expression is positively correlated with the activation of CD8<sup>+</sup> T cells, CD4<sup>+</sup> T cells, macrophages, and myeloid dendritic cells (DCs), but negatively correlated with myeloid-derived suppressor cells (MDSCs) according to Timer 2.0 dataset in LUAD. A positive value of Spearman’s Rho (Rho) denotes a positive correlation, while a negative value signifies a negative correlation. (<strong>D</strong>) Scheme showing the process of the clinical experiments. (<strong>E</strong> and <strong>F</strong>) Representative immunohistochemical (IHC) staining of S1PR1 in tissue microarray comprising 97 lung cancer and paired normal tissues. (<strong>G</strong>) The IHC scores for S1PR1 in our tissue microarray. (<strong>H</strong>) Representative IHC staining of lung cancer samples with high and low expression of S1PR1, CD8, and CD80. Scale bars, 50 μm. (<strong>I</strong>) Representative chest computed tomography (CT) images of responders and nonresponders before and after two or four circles of immunotherapies. (<strong>J</strong>) The plasma concentrations of S1P in 15 noncancer patients (NC patients) and 28 patients with lung cancer (LC patients). (<strong>K</strong>) The plasma concentrations of S1P in 11 responders and 17 nonresponders to immunotherapy. (<strong>L</strong>) The characteristics of the 28 patients with lung cancer who received PD-1/PD-L1 targeted therapies. Statistical significance was calculated via Student’s <em>t</em> test (***<em>P</em> &lt; 0.001; ****<em>P</em> &lt; 0.0001). <em>T</em>, tumor specimens; <em>N</em>, paired normal specimens; <em>B</em>, benign disease specimens; TPM, transcripts per million; HR, hazard ratio; LUSC, lung squamous cell carcinoma.</p></figcaption></figure><p>To further validate the clinical value of S1P, we conducted both a retrospective study involving 97 patients with lung cancer and a prospective study involving 28 patients with lung cancer and 15 patients with benign diseases (<a href="#F2" class="usa-link">Fig. 2D</a>). Immunohistochemical (IHC) staining on a tissue microarray comprising 97 paired lung cancer samples confirmed that S1PR1 expression was significantly lower in lung cancer tissues compared to that in paired normal tissues, supporting our previous findings from the TCGA dataset (<a href="#F2" class="usa-link">Fig. 2, E to G</a>, and fig. S5). Moreover, CD80- and CD8-positive cells had higher levels of S1PR1 in the tissues of lung cancer compared to CD80- and CD8-negative cells (<a href="#F2" class="usa-link">Fig. 2H</a>), suggesting that S1PR1 promoted the tumor infiltration of M1 macrophages and CD8<sup>+</sup> T cells. In the prospective study, we aimed to evaluate the correlation between plasma S1P levels and immunotherapy responses. Plasma S1P levels were measured in 28 patients with lung cancer before initiating programmed cell death protein 1 (PD-1)/PD-L1 targeted therapies. The results were compared with plasma S1P levels from 15 noncancer patients with benign diseases including lung bullae and bronchiectasis. After two or four cycles of immunotherapies, clinicians assessed the patients’ response rates. Representative chest computed tomography (CT) images of responders and nonresponders before and after immunotherapy were shown in <a href="#F2" class="usa-link">Fig. 2I</a>. The clinical characteristics of the 28 patients with lung cancer and 15 noncancer patients were listed in <a href="#F2" class="usa-link">Fig. 2L</a> and table S1. We found that patients with lung cancer had significantly lower plasma levels of S1P compared to noncancer controls (average level, 355.48 versus 670.73 nM) (<a href="#F2" class="usa-link">Fig. 2J</a>). Patients with higher plasma levels of S1P exhibited better response rates to immunotherapy than those with lower levels (<a href="#F2" class="usa-link">Fig. 2K</a>). Specifically, the average S1P level in responders was 439.15 nM, while, in nonresponders, it was 226.18 nM. Collectively, these findings provide robust evidence that key genes involved in S1P signaling, including SPHK1, SPNS2, and S1PR1, are down-regulated in lung cancer. Moreover, the expression of SPNS2 and S1PR1 appears to be prognostic, with lower levels associated with worse survival outcomes. Elevated plasma S1P levels are correlated with improved responses to αPDL1/PD-1 immunotherapy, underscoring the potential of S1P as a unique immunoadjuvant in the treatment of lung cancer.</p></section><section id="sec4"><h3 class="pmc_sec_title">Immune responses induced by S1P</h3>
<p>Given the critical role of S1P in activating immune cells through intricate mechanisms, we then investigated its impact on bone marrow–derived macrophages (BMDMs). Cytotoxicity of S1P to BMDMs was initially evaluated using cell counting kit–8 (CCK-8) assay. It was found that low concentrations of S1P (under 2.5 μM) exhibited negligible impact on BMDMs, whereas higher concentrations induced cytotoxicity (fig. S6A), indicating that S1P exerts beneficial effects on immune cell viability only at low concentrations. Moreover, low concentration of S1P (under 2.5 μM) did not affect the proliferation of Lewis lung carcinoma (LLC) cells (fig. S6B). On the basis of these observations, we selected 0.5 and 1.0 μM S1P for subsequent treatments of immune cells. Bone marrow–derived DCs (BMDCs) were incubated with 0.5 and 1.0 μM S1P for 24 hours, and their maturation was assessed by flow cytometry. It was found that the maturation of BMDCs (CD80<sup>+</sup>CD86<sup>+</sup>CD11c<sup>+</sup>) was significantly improved after S1P treatment (<a href="#F3" class="usa-link">Fig. 3, A and B</a>). To investigate the biological effects of S1P-treated BMDCs on T cells, carboxyfluorescein succinimidyl ester (CFSE)–labeled OT-I T cells were cocultured with S1P-treated or PBS-treated BMDCs in the presence of OVA<sub>257-264</sub> peptide for another 72 hours. As expected, flow cytometry revealed a higher level of T cells proliferation in cultures with S1P-treated BMDCs (<a href="#F3" class="usa-link">Fig. 3C</a> and fig. S7), indicating that S1P significantly enhances the biological function of BMDCs.</p>
<figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">Fig. 3. The role of S1P in the migration and viability of immune cells.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333694_sciadv.adw5001-f3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba3/12333694/1304d9fb232c/sciadv.adw5001-f3.jpg" loading="lazy" height="696" width="783" alt="Fig. 3."></a></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong> and <strong>B</strong>) Representative flow cytometric plots (A) and quantitative analysis (B) of mature DCs (CD80<sup>+</sup>CD86<sup>+</sup>) gating on CD11c<sup>+</sup> cells after treated with different concentrations of S1P. Data are presented as means ± SEM (<em>n</em> = 3). (<strong>C</strong>) Representative flow cytometry diagram showing the proliferation of CFSE-staining OT-I T cells after incubation with BMDCs with different pretreatments (<em>n</em> = 3). (<strong>D</strong> and <strong>E</strong>) Representative flow cytometric plots (D) and quantitative analysis (E) of M1-polarized BMDMs (CD80<sup>+</sup>) gating on F4/80<sup>+</sup>CD11b<sup>+</sup> cells after treatment with different concentrations of S1P. Data are presented as means ± SEM (<em>n</em> = 3). (<strong>F</strong>) The levels of lactate dehydrogenase (LDH) after coculture of S1P-treated BMDMs and LLC cells at radios of 10:1 or 15:1 for 24 hours. Data are presented as means ± SEM (<em>n</em> = 3). (<strong>G</strong>) Relative mRNA expression of M1 macrophages marker genes (iNOS, IL-6, IL-1β, and TNF-α) in S1P-treated BMDMs. Data are presented as means ± SEM (<em>n</em> = 3). (<strong>H</strong> and <strong>I</strong>) The levels of IL-6 (H) and TNF-α (I) in S1P-treated BMDMs were detected by enzyme-linked immunosorbent assay (ELISA). Data are presented as means ± SEM (<em>n</em> = 3). (<strong>J</strong> and <strong>K</strong>) Representative images (J) and the quantification (K) of migratory Raw264.7 cells stained with crystal violet at 18 hours after incubation with S1P. Data are presented as means ± SEM (<em>n</em> = 3). (<strong>L</strong>) The quantification of T cells in the lower chamber migrated from the upper chamber at 4 hours after incubation with S1P. Scale bars, 100 μm. Data are presented as means ± SEM (<em>n</em> = 3). Statistical significance was calculated via Student’s <em>t</em> test (n.s., not significant; *<em>P</em> &lt; 0.05; **<em>P</em> &lt; 0.01; ***<em>P</em> &lt; 0.001; ****<em>P</em> &lt; 0.0001).</p></figcaption></figure><p>Next, we evaluated the effects of S1P on the polarization of BMDMs, which were cultured in macrophage colony-stimulating factor (M-CSF; 40 ng/ml) for 5 to 7 days to generate M0 macrophages. These macrophages were then treated with 0.5 or 1.0 μM S1P for 24 hours. Flow cytometry analysis revealed that S1P treatment increased the proportion of M1 macrophages (CD80<sup>+</sup>F4/80<sup>+</sup>CD11b<sup>+</sup>) (<a href="#F3" class="usa-link">Fig. 3, D and E</a>). We also performed a lactate dehydrogenase (LDH) assay by coculturing BMDMs with LLC cells. After 24 hours pretreatments with PBS or S1P, BMDMs were cocultured with LLC cells at radios of 10:1 or 15:1 for another 24 hours. The LDH release assay showed that LLC cells exhibited higher LDH level after coculturing with S1P-treated BMDCs (<a href="#F3" class="usa-link">Fig. 3F</a>), suggesting that S1P obviously enhances the cytotoxic effects of BMDCs on tumors. Moreover, real-time polymerase chain reaction (PCR) analysis indicated that S1P treatment significantly up-regulated M1 macrophage markers including inducible nitric oxide synthase (iNOS), interleukin-1β (IL-1β), IL-6, and tumor necrosis factor–α (TNF-α) (<a href="#F3" class="usa-link">Fig. 3G</a>). Enzyme-linked immunosorbent assay (ELISA) confirmed that S1P-treated BMDMs produced higher levels of IL-6 and TNF-α, highlighting S1P’s role in enhancing macrophages’ antitumor activity (<a href="#F3" class="usa-link">Fig. 3, H and I</a>). To investigate the gradient-driven effect of S1P, we placed different concentrations of S1P on the bottom of a Transwell chamber, with T lymphocytes and Raw264.7 cells in the upper chamber in serum-free medium. After 18 hours, Raw264.7 cells that had migrated to the underside of the Transwell membrane were fixed with 4% paraformaldehyde and, subsequently, stained with crystal violet (<a href="#F3" class="usa-link">Fig. 3, J and K</a>). The number of T cells that migrated from the upper chamber to the lower chamber was quantified using a cell counting device after a 4-hour incubation (<a href="#F3" class="usa-link">Fig. 3L</a>). The Transwell assay demonstrated that S1P remarkedly promoted the migration of T lymphocytes cells and Raw264.7 cells, with higher concentrations exhibiting a more pronounced effect. Together, our results confirmed that S1P not only promoted the maturation of DCs but also enhanced the polarization of M1 macrophages. S1P induces the migration of both T lymphocytes and macrophages, highlighting its potential as a key mediator in immune response regulation.</p></section><section id="sec5"><h3 class="pmc_sec_title">Mechanism of S1P for immune regulation</h3>
<p>To investigate the signaling pathways responsible for the immune regulation mediated by S1P, we performed RNA sequencing (RNA-seq) on BMDMs treated with 1.0 μM S1P for 24 hours. The analysis identified 210 up-regulated and 57 down-regulated genes (fig. S10). The heatmap demonstrated a marked up-regulation of various immune-related genes in the S1P-treated group (<a href="#F4" class="usa-link">Fig. 4A</a>). Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis identified a significant up-regulation of inflammation-related signaling pathways, including cytokine-cytokine receptor interaction, TNF signaling, NLR signaling and IL-17 signaling (<a href="#F4" class="usa-link">Fig. 4, B and C</a>). Concurrently, gene set enrichment analysis (GSEA) confirmed the enrichment of pathways including NF-κB, JAK-STAT, TNF signaling, cytokine-cytokine receptor interaction, and the positive regulation of cytokine production (fig. S11). Key genes involved in these signaling pathways, including IL-1α, NOD1, C-C motif chemokine ligand 5 (CCL5), TNF receptor superfamily member 8 (TNFRSF8), Toll-like receptor 4 (TLR4), and colony stimulating factor 1 (CSF1), were further validated by real-time PCR (<a href="#F4" class="usa-link">Fig. 4D</a>).</p>
<figure class="fig xbox font-sm" id="F4"><h4 class="obj_head">Fig. 4. The potential signaling pathways responsible for the immune regulation of S1P.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333694_sciadv.adw5001-f4.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba3/12333694/4a16b8471d5c/sciadv.adw5001-f4.jpg" loading="lazy" height="913" width="778" alt="Fig. 4."></a></p>
<div class="p text-right font-secondary"><a href="figure/F4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) The heatmap of RNA-seq showing various genes concerning immune response up-regulated in S1P-treated BMDMs. (<strong>B</strong>) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analysis of differentially expressed genes between PBS and S1P groups. (<strong>C</strong>) Enriched chord diagram of the KEGG pathways and the related genes. (<strong>D</strong>) Relative mRNA expression of immune related genes in S1P or PBS-treated BMDMs. Data are presented as means ± SEM (<em>n</em> = 3). (<strong>E</strong>) The levels of p-STAT1, p-p65, and p-IκBα expressed in BMDMs after treated with 1 μM S1P for 15, 30, or 120 min. (<strong>F</strong>) The levels of NLRP3 expressed in BMDMs after treated with 1 μM S1P for 4 or 8 hours. h, hours. (<strong>G</strong>) The levels of NLRP3 in BMDMs after treated with Mdivi-1 (10 μM). (<strong>H</strong>) The levels of p-STAT1, p-p65, and p-IκBα expressed in BMDMs after Mdivi-1 (10 μM) and S1P (1 μM) treatment. (<strong>I</strong>) Mitochondrial ROS in Raw264.7 were detected by MitoSOX Red staining and analyzed by confocal microscopy after S1P (1 μM) and Mdivi-1 (10 μM) treatment. Scale bars, 10 μm. (<strong>J</strong>) Mitochondria in Raw264.7 were detected by TMRM and analyzed by confocal microscopy after S1P (1 μM) and Mdivi-1 (10 μM) treatment. Scale bars, 10 μm. (<strong>K</strong>) Illustration of the immunomodulatory effect of S1P, which enhances NLRP3 inflammasome, NF-κB, and JAK-STAT signaling pathways, through increased mitochondrial ROS production and mitochondrial biogenesis. Statistical significance was calculated via Student’s <em>t</em> test (n.s., not significant; *<em>P</em> &lt; 0.05; ***<em>P</em> &lt; 0.001).</p></figcaption></figure><p>To investigate the mechanism by which S1P promotes the polarization of M1 macrophages, BMDMs were incubated with different time of S1P (1.0 μM), and the activation of key transcription factors, STAT1 and NF-κB, which play central roles in immune cell activation and cytokine production (<a href="#R36" class="usa-link" aria-describedby="R36"><em>36</em></a>, <a href="#R37" class="usa-link" aria-describedby="R37"><em>37</em></a>), was assessed by Western blotting. As exhibited in <a href="#F4" class="usa-link">Fig. 4E</a>, treatment with 1 μM S1P led to a significant increase in phosphorylated STAT1 (p-STAT1) levels at 15, 30, or 120 min. Moreover, markers of NF-κB activation, such as phosphorylated p65 (p-p65) and phosphorylated inhibitor of nuclear factor κB (p-IκBα), were notably elevated. Notably, both the STAT1 and NF-κB signaling pathways peaked in activation around 30-min mark, after which they either remained elevated or gradually diminished.</p>
<p>In addition to STAT1 and NF-κB, we further investigated the expression of NLRP3 inflammasome, a key component of the innate immune system’s inflammasome complex (<a href="#R38" class="usa-link" aria-describedby="R38"><em>38</em></a>). Western blotting further confirmed that treatment with 1 μM S1P for 4 or 8 hours remarkedly up-regulated the expression of NLRP3 (<a href="#F4" class="usa-link">Fig. 4F</a>). Previous studies have suggested that active mitochondrial biogenesis and the resultant mtROS can activate key signaling pathways including NF-κB, JAK/STAT signaling, and the NLRP3 inflammasome, through epigenetic reprogramming (<a href="#R39" class="usa-link" aria-describedby="R39"><em>39</em></a>–<a href="#R41" class="usa-link" aria-describedby="R41"><em>41</em></a>). Mitochondrial division inhibitor 1 (Mdivi-1), a selective inhibitor of dynamin-related protein 1 (Drp-1), has been reported to prevent excessive mitochondrial fission by inhibiting the phosphorylation of Drp-1 at Ser<sup>616</sup> (<a href="#R42" class="usa-link" aria-describedby="R42"><em>42</em></a>). To explore whether the function of S1P depends on active mitochondrial biogenesis, BMDMs were pretreated with Mdivi-1 (10 μM) for 24 hours before S1P administration. As expected, Mdivi-1 could reverse the activation of NF-κB, JAK/STAT signaling, and NLRP3 inflammasome induced by S1P (<a href="#F4" class="usa-link">Fig. 4, G and H</a>).</p>
<p>Moreover, macrophages treated with S1P exhibited significantly higher levels of mtROS, as indicated by MitoSOX Red, a fluorescent indicator that selectively labels mitochondrial superoxide (<a href="#R43" class="usa-link" aria-describedby="R43"><em>43</em></a>), compared to PBS-treated group (<a href="#F4" class="usa-link">Fig. 4I</a> and fig. S12). To further assess S1P-mediated mitochondrial biogenesis, we used tetra-methyl-rhodamine methyl ester (TMRM), a cell-permeant dye that specifically labels mitochondria (<a href="#R44" class="usa-link" aria-describedby="R44"><em>44</em></a>). Confocal images revealed that S1P treatment induced significant mitochondrial fragmentation, transforming the typically elongated tubular networks into shorter, punctate structures (<a href="#F4" class="usa-link">Fig. 4J</a> and fig. S13). In addition, pretreatment with Mdivi-1 (10 μM for 24 hours) before S1P administration effectively counteracted the activation of mitochondrial biogenesis and mtROS production, indicating that the biological effects of S1P are dependent on mitochondrial dynamics (<a href="#F4" class="usa-link">Fig. 4, I and J</a>, and figs. S12 and S13). Collectively, our results indicate that S1P promotes mitochondrial biogenesis and mtROS production, which, in turn, leads to consistent activation of NLRP3 inflammasome, NF-κB, and JAK-STAT pathway, exhibiting the potential to remodel the TME from an immune suppressive to an immune-activated state, as illustrated in <a href="#F4" class="usa-link">Fig. 4K</a>.</p></section><section id="sec6"><h3 class="pmc_sec_title">Synthesis and characterization of S1P-αPDL1@Gel</h3>
<p>The above clinical data and in vitro experiments demonstrated that S1P signaling could effectively activate the antitumor immune response in lung cancer. S1P may enhance immune cell infiltration and remodel the immunologically cold TME of lung cancer. Given S1P’s complex biological role in body systems, precise modulation is crucial to maximize therapeutic benefits while minimizing adverse effects. However, delivering S1P as a therapeutic agent presents several challenges. First, as a small molecule, the precise and controlled release of S1P is difficult due to their rapid diffusion and potential instability. The pharmacological efficacy of S1P relies on establishing a concentration gradient between the tumor and the bloodstream, but the conventional systemic administration lacks tissue or organ specificity. To overcome these hurdles, sodium alginate (ALG) hydrogel (<a href="#R45" class="usa-link" aria-describedby="R45"><em>45</em></a>, <a href="#R46" class="usa-link" aria-describedby="R46"><em>46</em></a>) was chosen as an ideal delivery platform for the sustained and sequential release of S1P and αPDL1, due to the smaller molecular size of S1P compared to αPDL1. The initially released S1P may enhance the immune cell infiltration and convert the cold tumor to an inflamed one. Subsequently, the released αPDL1 can further reveal the identity of tumor cells and restore the function of immune cells, thereby revoking the tumor’s immune evasion mechanism.</p>
<p>For synthesizing the S1P-αPDL1@Gel, S1P and αPDL1 were gradually added to the ALG solution with stirring to ensure homogenous distribution. Calcium chloride (CaCl<sub>2</sub>) was then introduced to induce cross-linking and stabilize the hydrogel’s three-dimensional network structure (<a href="#F5" class="usa-link">Fig. 5, A and B</a>). Through optimization, we identified a combination of 4 wt % ALG and 1 wt % CaCl<sub>2</sub> in a ratio of 2:1, forming a relatively stiff hydrogel with a moderate gelation rate (<a href="#F5" class="usa-link">Fig. 5C</a>). Scanning electron microscopy (SEM) analysis of the freeze-dried hydrogel scaffolds revealed a highly porous structure (<a href="#F5" class="usa-link">Fig. 5D</a>). Rheological testing confirmed that the storage modulus (<em>G</em>′) of the S1P-αPDL1@Gel was greater than the loss modulus (<em>G</em>″), and the <em>G</em>′ and <em>G</em>″ of the hydrogel remained stable at ~3 and 1 kPa for 5 min, respectively, indicating favorable gel stability (<a href="#F5" class="usa-link">Fig. 5, E and F</a>). Furthermore, when the stress exceeded 23%, the curve of the <em>G</em>′ and <em>G</em>″ underwent a crossover, indicating that the threshold for its stress was 23% (<a href="#F5" class="usa-link">Fig. 5G</a>). Within the frequency of 10 Hz, the <em>G</em>′ and <em>G</em>″ of the hydrogel remained stable (<a href="#F5" class="usa-link">Fig. 5H</a>). Furthermore, we investigated the in vivo gelation and degradation behavior of the hydrogel. C57BL/6 mice were subcutaneously injected with solutions containing S1P, αPDL1, ALG, and CaCl<sub><sub>2</sub></sub>. Upon injection, the solutions rapidly formed a solid hydrogel in situ. We monitored the degradation process over time, and a quantitative assessment of the S1P-αPDL1@Gel degradation behavior in vivo indicated that ~75% of the hydrogel remained 8 days postinjection. The slow degradation kinetics of S1P-αPDL1@Gel highlight its remarkable stability and potential suitability for controlled drug release applications (<a href="#F5" class="usa-link">Fig. 5, I and J</a>).</p>
<figure class="fig xbox font-sm" id="F5"><h4 class="obj_head">Fig. 5. The synthesis and characterization of S1P-αPDL1@Gel.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333694_sciadv.adw5001-f5.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba3/12333694/a55d725e3949/sciadv.adw5001-f5.jpg" loading="lazy" height="766" width="783" alt="Fig. 5."></a></p>
<div class="p text-right font-secondary"><a href="figure/F5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) Schematic illustration of the synthesis of S1P-αPDL1@Gel. (<strong>B</strong>) Morphology transitions of ALG hydrogel from a fluid to a solid state upon the addition of CaCl<sub>2</sub>. (<strong>C</strong>) Photographs of hydrogel with different concentrations of sodium ALG and calcium chloride. (<strong>D</strong>) Representative SEM image of freeze-dried ALG hydrogel. Scale bar, 4 μm. (<strong>E</strong>) Changes in <em>G</em>′ and <em>G</em>″ of ALG hydrogel over time. (<strong>F</strong>) Scheme showing the process of rheological testing of ALG hydrogel. (<strong>G</strong>) Changes in <em>G</em>′ and <em>G</em>″ of ALG hydrogel with varying strain. (<strong>H</strong>) Changes in <em>G</em>′ and <em>G</em>″ of ALG hydrogel with varying frequency. (<strong>I</strong>) Representative ex vivo images of S1P-αPDL1@Gel after subcutaneous injection into mice captured at different time points. (<strong>J</strong>) Quantitative evaluation of S1P-αPDL1@Gel degradation behavior in vivo over time. Data are presented as means ± SEM (<em>n</em> = 3). (<strong>K</strong>) Scheme showing the in vitro release assay of S1P-IgG hydrogel using a Transwell chamber. (<strong>L</strong>) Release curve of S1P and IgG from S1P-IgG@Gel over time. Data are presented as means ± SEM (<em>n</em> = 3). (<strong>M</strong>) Fluorescence images of mice treated with free Cy5.5-labeled IgG or Cy5.5-labeled IgG@Gel at different time points. (<strong>N</strong>) Statistic analysis of total radiant efficiency of the in vivo release of IgG. Data are presented as means ± SEM (<em>n</em> = 3). (<strong>O</strong>) Statistic analysis of total radiant efficiency of the in vivo release assay of S1P. Data are presented as means ± SEM (<em>n</em> = 3). (<strong>P</strong>) Fluorescence images of mice treated with free Cy7-labeled S1P or Cy7-labeled S1P@Gel at different time points. Statistical significance was calculated via Student’s <em>t</em> test (n.s., not significant; *<em>P</em> &lt; 0.05; **<em>P</em> &lt; 0.01; ***<em>P</em> &lt; 0.001).</p></figcaption></figure><p>Additionally, we investigated the release profiles of S1P and αPDL1 from the hydrogel scaffold. Due to its affordability and similar properties, immunoglobulin G (IgG) was used to replace αPDL1 in the release assay. Cyanine 7 (Cy7)–<em>N</em>-hydroxysuccinimide (NHS) and Cy5.5-NHS were used to label S1P and IgG, respectively. The hydrogel scaffold containing S1P and IgG was placed in the upper chamber of a Transwell plate, and the release of both molecules was monitored at different time points (<a href="#F5" class="usa-link">Fig. 5K</a>). Most S1P was released within one day, whereas IgG sustained release for 7 days (<a href="#F5" class="usa-link">Fig. 5L</a>). To evaluate the in vivo release behavior of S1P and αPDL1, hydrogel or PBS containing S1P and IgG was intratumorally injected into LLC tumors. Consistent with in vitro results, in vivo fluorescence imaging demonstrated that S1P and IgG delivered by hydrogel exhibited a sustained release profile. S1P-αPDL1@Gel retained S1P for up to 4 days and αPDL1 for up to 8 days, doubling the release duration compared to free drugs (<a href="#F5" class="usa-link">Fig. 5, M to P</a>). These results suggest that ALG hydrogel is a reliable platform for the sustained and sequential release of S1P and αPDL1, which may facilitate the immune cell infiltration and restore their ability to recognize and kill tumor cells.</p></section><section id="sec7"><h3 class="pmc_sec_title">In vivo antitumor efficacy of S1P-αPDL1 hydrogel</h3>
<p>To evaluate the in vivo therapeutic efficacy of S1P-αPDL1@gel against lung cancer, we subcutaneously implanted 5 × 10<sup>4</sup> LLC cells into C57BL/6 mice. After 7 days, the tumor-bearing mice received intratumorally injections of PBS (50 μl), αPDL1@Gel (50 μl; 50 μg of αPDL1 per mouse), S1P@Gel (50 μl; 5 μg of S1P per mouse), free S1P-αPDL1 (50 μl; 5 μg of S1P and 50 μg of αPDL1 per mouse), or S1P-αPDL1@Gel (50 μl; 5 μg of S1P and 50 μg of αPDL1 per mouse) as shown in <a href="#F6" class="usa-link">Fig. 6A</a>. Tumor sizes and body weights of mice in different groups were measured every other day. Compared to the PBS group, both S1P@Gel and αPDL1@Gel exhibited mild tumor suppression. In contrast, due to the synergistic effects of S1P and αPDL1, mice treated with either free S1P-αPDL1 or S1P-αPDL1@Gel exhibited enhanced antitumor effects. Notably, mice receiving S1P-αPDL1@Gel showed obviously smaller tumor volume compared to those treated with free S1P-αPDL1 (<a href="#F6" class="usa-link">Fig. 6, B and D</a>), suggesting that the sequential release of S1P and αPDL1 from the hydrogel contributed to the enhanced therapeutic efficacy. After 14 days, the mice were euthanized, and the tumor volumes among different groups were evaluated. The average tumor volume in the S1P-αPDL1@Gel group was only one-quarter of that in the PBS group (fig. S14). Survival was monitored over time, with median survival times of 16.5 days for PBS-treated mice, 20 days for αPDL1@Gel, 20.5 days for S1P@Gel, 28 days for free S1P-αPDL1, and 33.5 days for S1P-αPDL1@Gel (<a href="#F6" class="usa-link">Fig. 6C</a>). Meanwhile, nearly no difference in body weight was observed among different groups (<a href="#F6" class="usa-link">Fig. 6E</a>), indicating that locally applied S1P-αPDL1@Gel caused negligible side effects.</p>
<figure class="fig xbox font-sm" id="F6"><h4 class="obj_head">Fig. 6. Therapeutic effect of S1P-αPDL1 hydrogel.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333694_sciadv.adw5001-f6.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba3/12333694/c92875708b9c/sciadv.adw5001-f6.jpg" loading="lazy" height="1014" width="781" alt="Fig. 6."></a></p>
<div class="p text-right font-secondary"><a href="figure/F6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) Schematic representation of the tumor inoculation and treatment procedure on subcutaneous tumor model. (<strong>B</strong>) The tumor growth curves of mice in different groups. Data are presented as means ± SEM (<em>n</em> = 6). (<strong>C</strong>) Survival curves of subcutaneous tumor model (<em>n</em> = 6). (<strong>D</strong>) Individual tumor growth curves of mice receiving different treatments. (<strong>E</strong>) Body weights of mice in different groups. Data are presented as means ± SEM (<em>n</em> = 6). (<strong>F</strong>) Schematic representation of treatment procedure on tumor recurrence model. (<strong>G</strong>) The tumor growth curves of mice in different groups. Data are presented as means ± SEM (<em>n</em> = 6). (<strong>H</strong>) Survival curves of postsurgical recurrence model (<em>n</em> = 6). (<strong>I</strong>) Individual tumor growth curves of mice receiving different treatments. (<strong>J</strong>) Body weights of mice in different groups. Data are presented as means ± SEM (<em>n</em> = 6). (<strong>K</strong>) Representative hematoxylin and eosin (H&amp;E) staining images of residual tumors after different treatments. Scale bars, (top) 5 mm and (bottom) 100 μm. (<strong>L</strong>) Representative TUNEL and Ki-67 staining of excised tumors in mice with different treatments. Scale bars, 100 μm. (<strong>M</strong>) Relative quantification of the mean fluorescence intensity (MFI) of TUNEL staining images. Data are presented as means ± SEM (<em>n</em> = 3). (<strong>N</strong>) Relative quantification of MFI of Ki-67 staining images. Data are presented as means ± SEM (<em>n</em> = 3). (<strong>O</strong>) S1P levels in tumor tissues detected by ELISA. Data are presented as means ± SEM (<em>n</em> = 6). (<strong>P</strong>) Serum levels of S1P after different treatments. Data are presented as means ± SEM (<em>n</em> = 6). G1, PBS; G2, αPDL1@Gel; G3, S1P@Gel; G4, free S1P-αPDL1; G5, S1P-αPDL1@Gel. Statistical significance was calculated via one-way analysis of variance (ANOVA) with a Tukey post hoc test or log-rank test (n.s., not significant; *<em>P</em> &lt; 0.05; **<em>P</em> &lt; 0.01; ***<em>P</em> &lt; 0.001; ****<em>P</em> &lt; 0.0001).</p></figcaption></figure><p>In addition to the primary tumors, residual tumors after surgery of advanced lung tumors often lead to tumor recurrence and metastasis, significantly affecting long-term survival. To assess whether local administration of S1P-αPDL1@Gel could prevent tumor recurrence, we performed experiments using an LLC incomplete tumor resection model. As illustrated in <a href="#F6" class="usa-link">Fig. 6F</a>, most tumors were surgically removed, leaving ~5% of the original tumor volume when the tumors reached 150 cm<sup>3</sup>. Following resection, different formulations as above were injected directly into the resection cavity. After 14 days, all six mice in the PBS group showed notable recurrence. Consistent with above findings, mice treated with S1P-αPDL1@Gel exhibited the most effective therapeutic effect in controlling tumor recurrence (<a href="#F6" class="usa-link">Fig. 6, G and I</a>), with three of the six mice showing significant reduced recurrence (tumor volume &lt; 200 cm<sup>3</sup>). Mice receiving nonencapsulated S1P-αPDL1 exhibited less tumor suppression. Furthermore, after tumor resection, the median survival times for mice receiving PBS, αPDL1@Gel, S1P@Gel, and free S1P-αPDL1 were 17.5, 22.5, 22.5, and 26 days, respectively (<a href="#F6" class="usa-link">Fig. 6H</a>). Impressively, four mice treated with S1P-αPDL1@Gel survived beyond 40 days, and two others lived for 32 and 35 days, respectively, indicating a significant survival advantage. Similarly, body weights remained stable across all treatment groups, indicating the favorable biocompatibility and biosafety of the S1P-αPDL1 hydrogel (<a href="#F6" class="usa-link">Fig. 6J</a>).</p>
<p>The potential utility of S1P-αPDL1@Gel was further confirmed by histological analysis. Hematoxylin and eosin (H&amp;E) staining, along with immunofluorescence staining of the residual tumors, were used to assessed cell apoptosis and proliferation via terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate (dUTP) nick end labeling (TUNEL) and Ki-67 staining, respectively (<a href="#F6" class="usa-link">Fig. 6, K to N</a>). TUNEL and Ki-67 staining confirmed that the treatments with αPDL1@Gel, S1P@Gel, free S1P-αPDL1, and S1P-αPDL1@Gel significantly reduced cell proliferation and promoted tumor apoptosis compared to the PBS group. Among the treatments, S1P-αPDL1@Gel showed the greatest efficacy, achieving the most pronounced reduction in Ki-67 expression (80.7%) and the highest apoptosis induction (6.5-fold increase). To further investigate the role of S1P, we measured the levels of S1P in both residual tumor and serum by ELISA. As expected, mice treated with S1P-containing hydrogel exhibited higher S1P levels in the residual tumor compared to the other groups, with no significant differences in serum SIP levels across all groups (<a href="#F6" class="usa-link">Fig. 6, O and P</a>). These findings suggest that the S1P gradient between tumors and bloodstream might enhance immune cell infiltration and viability, contributing to tumor suppression. To investigate the biosafety of the S1P-αPDL1 hydrogel, healthy mice were administered a subcutaneous injection of S1P-αPDL1@Gel (5 μg of S1P and 50 μg of αPDL1 per mouse) in the dorsal region. A comprehensive evaluation was conducted through complete blood count (CBC) and biochemical tests, including alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, and serum urea levels, on days 1 and 7 after treatment. Compared to healthy controls, mice treated with S1P-αPDL1@Gel exhibited nearly no adverse alterations in CBC or biochemical parameters. Moreover, 1-month posttreatment, major organs including the heart, liver, spleen, lungs, and kidneys were harvested for H&amp;E staining. It was found that S1P-αPDL1@Gel induced negligible toxicity to these major organs, suggesting that S1P-αPDL1@Gel induced nearly no hepatotoxicity, nephrotoxicity, or hematopoietic toxicity (fig. S15).</p></section><section id="sec8"><h3 class="pmc_sec_title">Immune responses induced by S1P-αPDL1 hydrogel</h3>
<p>On the basis of the above results, we hypothesized that S1P-αPDL1@Gel may remodel the local TME by establishing an S1P gradient between the bloodstream and tumor tissues. To further elucidate the underlying mechanisms responsible for antitumor effects, we harvested subcutaneous tumors 6 days after treatment with different hydrogel formulations. Flow cytometry was performed to evaluate the presence and polarization of various immune cells, including DCs, TAMs, and lymphocytes, within the tumor. Our findings revealed a significant increase in the population of mature DCs (CD80<sup>+</sup>CD86<sup>+</sup>CD11c<sup>+</sup>) following treatment with αPDL1@Gel, S1P@Gel, free S1P-αPDL1, or S1P-αPDL1@Gel, compared to the PBS controls. Notably, mature DCs increased from 12.6% in the PBS group to 25.3% in the S1P-αPDL1@Gel group (<em>P</em> &lt; 0.0001) (<a href="#F7" class="usa-link">Fig. 7, A and B</a>). A similar trend was observed for M1-polarized TAMs (CD80<sup>+</sup>F4/80<sup>+</sup>CD11b<sup>+</sup>), with S1P-αPDL1@Gel treatment resulting in the most significant increase (~44.9%, <em>P</em> &lt; 0.0001) among all treatments (<a href="#F7" class="usa-link">Fig. 7, C and D</a>). Immunofluorescence staining further confirmed an increase in intratumoral CD80<sup>+</sup> M1 TAMs following treatment with S1P@Gel (<em>P</em> &lt; 0.05), S1P-αPDL1 (<em>P</em> &lt; 0.01), or S1P-αPDL1@Gel (<em>P</em> &lt; 0.001) compared to PBS controls (<a href="#F7" class="usa-link">Fig. 7, I and L</a>). These results indicate that both S1P and αPDL1, whether administered alone or in combination, enhance the infiltration of mature DCs and M1 TAMs, with the combination therapy in the hydromel formulation demonstrating the highest efficacy.</p>
<figure class="fig xbox font-sm" id="F7"><h4 class="obj_head">Fig. 7. Immune responses after S1P-αPDL1 hydrogel treatment.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12333694_sciadv.adw5001-f7.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba3/12333694/4ac4972ec4f1/sciadv.adw5001-f7.jpg" loading="lazy" height="913" width="748" alt="Fig. 7."></a></p>
<div class="p text-right font-secondary"><a href="figure/F7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong> and <strong>B</strong>) Representative flow cytometric plots (A) and quantitative analysis (B) of the mature DCs (CD80<sup>+</sup>CD86<sup>+</sup>) gating on CD11c<sup>+</sup>CD45<sup>+</sup> cells. Data are presented as means ± SEM (<em>n</em> = 5). (<strong>C</strong> and <strong>D</strong>) Representative flow cytometric plots (C) and quantitative analysis (D) of the infiltrated M1-polarized TAMs (CD80<sup>+</sup>) gating on F4/80<sup>+</sup>CD11b<sup>+</sup> cells. Data are presented as means ± SEM (<em>n</em> = 5). (<strong>E</strong>) Representative flow cytometric analysis of T cell infiltration gating on CD3<sup>+</sup> cells within the tumor. (<strong>F</strong> and <strong>H</strong>) Relative quantification of CD4<sup>+</sup> (F) and CD8<sup>+</sup>T (H) cells within the tumor. Data are presented as means ± SEM (<em>n</em> = 5). (<strong>G</strong> and <strong>J</strong>) Representative flow cytometric plots (G) and quantitative analysis (J) of IFN-γ<sup>+</sup> T cells gating on CD3<sup>+</sup>CD8<sup>+</sup> cells within the tumor. Data are presented as means ± SEM (<em>n</em> = 5). (<strong>I</strong>) Representative immunofluorescent staining of CD80 (green) in paraffin sections of excised tumors. Scale bars, 100 μm. (<strong>K</strong>) Representative immunofluorescent staining of CD4 (green) and CD8 (red) in paraffin sections of excised tumors. Scale bars, 100 μm. (<strong>L</strong>) Relative quantification of MFI of CD80<sup>+</sup> cells after different treatments. Data are presented as means ± SEM (<em>n</em> = 3). (<strong>M</strong> and <strong>N</strong>) Relative quantification of MFI of CD4<sup>+</sup> (M) and CD8<sup>+</sup> (N) T cells after different treatments. Data are presented as means ± SEM (<em>n</em> = 3). (<strong>O</strong> to <strong>Q</strong>) Expression levels of immunostimulatory cytokines including IL-6 (O), TNF-α (P), and IFN-γ (Q) in tumor tissues after different treatments. G1, PBS; G2, αPDL1@Gel; G3, S1P@Gel; G4, free S1P-αPDL1; G5, S1P-αPDL1@Gel. Statistical significance was calculated via one-way ANOVA with a Tukey post hoc test (*<em>P</em> &lt; 0.05; **<em>P</em> &lt; 0.01; ***<em>P</em> &lt; 0.001; ****<em>P</em> &lt; 0.0001).</p></figcaption></figure><p>Following treatment with either S1P-αPDL1 or S1P-αPDL1@Gel, there was also a notable increase in the absolute number of tumor-infiltrating lymphocytes (CD3<sup>+</sup>) (fig. S19). Specifically, an increase in both CD8<sup>+</sup> T cells (CD3<sup>+</sup>CD8<sup>+</sup>) and CD4<sup>+</sup> T cells (CD3<sup>+</sup>CD4<sup>+</sup>) was observed in the TME after S1P-αPDL1@Gel treatment, but not with αPDL1@Gel, S1P@Gel or free S1P-αPDL1 treatment (<a href="#F7" class="usa-link">Fig. 7, E, F, and H</a>), suggesting that monotherapy with S1P or αPDL1 alone is insufficient to promote cytotoxic T cell infiltration, whereas the hydrogel-mediated two-step therapy could effectively activate this process. The percentage of effector CD8<sup>+</sup> T cells, defined as IFN-γ–positive CD8<sup>+</sup> T cells (CD3<sup>+</sup>CD8<sup>+</sup>IFN-γ<sup>+</sup>), was markedly increased in mice treated with S1P-αPDL1@Gel (~11.9%) compared to that of the PBS controls (~2.0%) (<a href="#F7" class="usa-link">Fig. 7, G and J</a>). Immunofluorescence staining of the residual tumors further verified that S1P-αPDL1@Gel enhanced the infiltration of both CD4<sup>+</sup> T (<em>P</em> &lt; 0.001) and CD8<sup>+</sup> T (<em>P</em> &lt; 0.001) cells (<a href="#F7" class="usa-link">Fig. 7, K, M, and N</a>). Furthermore, cytokines including IL-6, TNF-α, and IFN-γ within tumor tissues were investigated. ELISAs showed that both free S1P-αPDL1 and S1P-αPDL1@Gel treatments increased the secretion of IL-6 and TNF-α (<a href="#F7" class="usa-link">Fig. 7, O and P</a>) (<em>P</em> &lt; 0.01), but only S1P-αPDL1@Gel treatment significantly promoted the secretion of IFN-γ (<a href="#F7" class="usa-link">Fig. 7Q</a>) (<em>P</em> &lt; 0.001). The enhanced secretion of cytokines further confirms the critical role of S1P-αPDL1@Gel in immune regulation. These results indicate a notable enrichment of mature DCs, M1 TAMs, CD8<sup>+</sup> T cells, and CD4<sup>+</sup> T cells, concomitant with up-regulated levels of IL-6, TNF-α, and IFN-γ within tumors.</p></section></section><section id="sec9"><h2 class="pmc_sec_title">DISCUSSION</h2>
<p>Immunotherapy has achieved remarkable clinical efficiency in the treatment of lung cancer in recent years, bringing new therapeutic options for patients resistant to targeted therapy and chemoradiotherapy. However, patients with immune-excluded or immune-desert TME often fail to respond to immunotherapy. In this work, we identified that plasma S1P levels were significantly down-regulated in patients with lung cancer who did not respond to anti–PD-1/PD-L1 therapy. The average plasma S1P level in responders was 439.15 nM, while, in nonresponders, it was 226.18 nM. In addition, a tissue microarray comprising 97 paired lung cancer samples revealed that the primary S1PR, S1PR1, was also down-regulated in tumor tissues. Notably, patients with low S1PR1 expression were associated with worse survival outcomes. Although the immunomodulatory role of S1P is well-documented, its function within the TME remains poorly understood. A recent study by Luca <em>et al</em>. (<a href="#R47" class="usa-link" aria-describedby="R47"><em>47</em></a>) suggested that SPHK1 deficiency could lead to significant accumulation of M2-polarized macrophages and suppression of tumor growth in animal models of Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS)–mutated LUAD. SPHK1 is the key enzyme responsible for catalyzing the sphingosine phosphorylation to generate S1P. We hypothesized that the decreased S1P levels caused by SPHK1 deficiency may contribute to the dysregulated TME. Regarding its mechanism of action, S1P enhances immune cell migration and viability through the promotion of mitochondrial biogenesis and mtROS production, which, in turn, activates inflammatory signaling pathways, including NLRP3 inflammasome, NF-κB, and JAK-STAT. To our knowledge, this mechanism has not been previously reported in the context of lung cancer. These clinical and biological findings underscore the potential of S1P as an innovative immunoadjuvant for treating tumors with immune-excluded or immune-desert phenotype tumors.</p>
<p>Inspired by these findings, we developed the innovative S1P-αPDL1@Gel, designed for the sustained and sequential release of S1P and αPDL1 within the tumor. According to the release behaviors of S1P and αPDL1, it was found that S1P-αPDL1@Gel retained S1P in the tumor for up to 4 days and αPDL1 for up to 8 days, significantly extending the release duration. The initially released S1P establishes a concentration gradient between tumor and bloodstream, promoting the infiltration of immune cells. The artificially engineered trafficking pathway of immune cells ensures the reconfiguration of the TME in cold tumors. Subsequently, the released αPDL1 abrogates the tumor immune evasion potential and restores the functionality of T cells and macrophages. Residual tumors following surgeries for advanced lung cancer frequently result in tumor recurrence and metastasis. Local administration of S1P-αPDL1@Gel may effectively drive the infiltration and antitumor effects of immune cells without nonspecific damage to normal tissues. The straightforward and well-tolerated treatment approach fills the therapeutic gap for residual tumors. This breakthrough underscores the potential of S1P-αPDL1@Gel in remodeling the TME of cold tumors and suppressing tumor recurrence. Recently, several studies have used hydrogels as drug delivery platforms to modulate TME. For example, an in situ–formed immunotherapeutic hydrogel, incorporating antiCD47 antibody-loaded CaCO<sub>3</sub> nanoparticles, effectively revised the immunosuppressive TME and induced systemic immunological responses (<a href="#R48" class="usa-link" aria-describedby="R48"><em>48</em></a>). Our present work distinguishes itself from previous studies on immunomodulatory hydrogels through several key innovations. First, the hydrogel is fabricated from biodegradable materials using a simple preparation process, enhancing its potential for rapid clinical translation. Notably, S1P-αPDL1@Gel delivers S1P, a unique immunomodulatory molecule that we have identified as capable of recruiting immune cells into tumor tissues. Synergistic therapy combining S1P and PD-L1 blockade significantly suppresses tumor growth and reduces postoperative recurrence. The immunoregulatory role of S1P is robustly supported by both clinical evidences, validated in vivo, and underscored by rigorous mechanism elucidation, providing a comprehensive rationale for its therapeutic efficacy. Prospectively, S1P-incorporated hydrogel could potentially synergize with the sustained release of tumor antigens at the administration site, thereby creating an innovative tumor vaccine strategy. Moreover, the antitumor immunity of S1P-αPDL1@Gel may be further enhanced by integrating it with conventional adjuvant therapies, such as radiotherapy or chemotherapy.</p></section><section id="sec10"><h2 class="pmc_sec_title">MATERIALS AND METHODS</h2>
<section id="sec11"><h3 class="pmc_sec_title">Materials, cell lines, animals, and patients</h3>
<p>S1P (HY-108496) was purchased from MedChemExpress, Cy7-NHS (<a href="https://www.ncbi.nlm.nih.gov/nuccore/D10018" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">D10018</a>) and Cy5.5-NHS (<a href="https://www.ncbi.nlm.nih.gov/nuccore/D10020" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">D10020</a>) were purchased from Duofluor Inc., and pharmaceutical-grade ALG was obtained from J&amp;K Scientific. CCK-8 (RM02823) was purchased from ABclonal Technology (WuHan, China). All other chemicals were purchased from Sigma-Aldrich. The LLC mouse cell line was acquired from the National Collection of Authenticated Cell Cultures. LLC cells were cultured in high-glucose Dulbecco’s modified Eagle’s medium (Gibco BRL, Gaitherburg, MD, USA), enriched with 10% fetal bovine serum (FBS; Gibco) and 1% penicillin- streptomycin antibiotic mix (Gibco). The serum-free cell cryopreservation solution (FL10020L) and trypsin-EDTA digestion solution (FL20011) were purchased from Bioland Biotechnology Co. Ltd. (Hangzhou, China). The cells were maintained in an incubator with a 5% CO<sub>2</sub> environment at a temperature of 37°C. C57BL/6 mice, aged 5 to 6 weeks, were purchased from the Shanghai Model Organisms Center Inc. BMDCs and BMDMs were isolated from the femurs and tibias of 7-week-old C57BL/6 mice. Both BMDCs and BMDMs were cultured in RPMI 1640 medium (Gibco BRL, Gaitherburg, MD, USA). All animal experiments conducted adhered to pertinent regulations and received authorization from the Animal Ethics Committee of Soochow University (no. ECSU-2019000198).</p>
<p>The study analyzed 97 tissue specimens and 28 plasma samples from patients with histologically confirmed NSCLC, as diagnosed by senior lung pathologists. Plasma samples were collected before treatment with two or four cycles of PD-L1/PD-1 inhibitors. Tumor regression in response to immunotherapy was assessed through chest CT imaging by clinicians. According to the CT evaluations postimmunotherapy, patients with ≥30% reduction in the total diameter of target lesions were classified as responders, while those with &lt;30% reduction were deemed nonresponders. Additionally, 15 plasma samples of noncancer patients with begin conditions, such as lung bullae and bronchiectasis, were included for comparison. All patients were recruited from February 2024 to May 2024, and all individuals provided their written consent after being fully informed. The study was approved by the Ethical Committee of Shanghai General Hospital (2024KS525).</p></section><section id="sec12"><h3 class="pmc_sec_title">Synthesis of S1P-αPDL1 hydrogel</h3>
<p>For the synthesis of S1P-αPDL1@Gel, we use a 50-μl volume of hydrogel as an example to illustrate the process. S1P (5 μg) and αPD-L1 (50 μg) were first mixed in PBS buffer to a total volume of 12 μl. Then, the mixture was stirred with 22 μl of ALG (60 mg/ml) at 4°C for 1 hour. The 34 μl of ALG (40 mg/ml) containing 5 μg of S1P and 50 μg of αPD-L1 was then mixed with 16 μl of calcium chloride (10 mg/ml) solution to form a relatively stiff hydrogel with a moderate gelation rate.</p></section><section id="sec13"><h3 class="pmc_sec_title">Drug release behavior of S1P-αPDL1 hydrogel</h3>
<p>To investigate the release kinetics of S1P-αPDL1 hydrogel in vitro, Cy7-NHS (Duofluor Inc., China) and Cy5.5-NHS (Duofluor Inc., China) were used to label S1P and IgG, respectively. The hydrogel scaffold (100 μl) containing 10 μg of S1P and 100 μg of IgG was placed in the upper chamber of a Transwell plate (pore size of 8 μm), and 600 μl of PBS was added into the lower chamber. At various intervals, 100 μl of PBS was harvested, and an equivalent volume of fresh PBS was replenished. The amount of released S1P and IgG were evaluated according to the fluorescence signal from Cy7 and Cy5.5.</p>
<p>To determine the release behavior of the S1P-αPDL1 hydrogel (50 μl of hydrogel containing 5 μg of S1P and 50 μg of IgG) in vivo, sodium ALG mixed with 5 μg of S1P and 50 μg of IgG, along with calcium chloride solution, were injected through the dual syringes. The remaining S1P and IgG in tumor at different time were determined using in vivo fluorescence imaging.</p></section><section id="sec14"><h3 class="pmc_sec_title">Quantitative real-time PCR</h3>
<p>Total RNA was isolated using TRIzol reagent (Invitrogen) and subsequently converted to cDNA using a cDNA synthesis kit (ABclonal Technology, WuHan, China, RK20429). Quantitative real-time PCR was used to assess gene expression levels using SYBR Green Fast qPCR Mix (ABclonal Technology, WuHan, China, RK21203). The specific primers used in the experiment were as follows: iNOS [forward (F): 5′-gcttgcccctggaagtttct-3′; reverse (R): 5′-cctcacatactgtggacggg-3′], IL-6 (F: 5′-cggccttccctacttcacaa-3′; R: 5′-ttctgcaagtgcatcatcgt-3′), TNF-α (F: 5′-tgagcacagaaagcatgatcc-3′; R: 5′-gccatttgggaacttctcatc-3′), IL-1β (F: 5′-cgtggaccttccaggatgag-3′; R: 5′-catctcggagcctgtagtgc-3′), CSF1 (F: 5′-ccttcttcgacatggctggg-3′; R: 5′-actgtcgatcaactgctgca-3′), IL1-α (F: 5′-gagagccgggtgacagtatc-3′; R: 5′-aaggtgctgatctgggttgg-3′), NOD1 (F: 5′-tcgtcctgcatcacttccac-3′; R: 5′-ggtgatctggttgacgctga-3′), CCL5 (F: 5′-accatcatcctcactgcagc-3′; R: 5′-gggagaggtaggcaaagcag-3′), TNFRSF8 (F: 5′-cccacctctccattgtccac-3′; R: 5′-aacacaggagaaaggagccg-3′), and TLR4 (F: 5′-gggaacaaacagcctgagaca-3′; R: 5′-ctgaaaatccaggtgctgcag-3′).</p></section><section id="sec15"><h3 class="pmc_sec_title">Western blotting</h3>
<p>Cells were lysed with cell lysis buffer (Yeasen Biotech) enriched with a protease inhibitor cocktail (Yeasen Biotech) and phenylmethylsulfonyl fluoride (Yeasen Biotech). Protein concentrations were quantified by bicinchoninic acid (BCA) assay (Thermo Scientific). Protein extracts were separated by SDS–polyacrylamide gel electrophoresis according to the standard protocols. Corresponding primary and secondary antibodies were adopted to detect the expression of indicated proteins. Antibodies used in this study were as follows: P65 (10745-1-AP, 1:1000), NLRP3 (68102-1-Ig, 1:1000), IκBα (10268-1-AP, 1:1000), p-IκBα (82349-1-RR, 1:1000), horseradish peroxidase (HRP)–conjugated goat anti-rabbit (SA00001-2, 1:5000), HRP-conjugated goat anti-mouse (SA00001-1, 1:5000), and β-actin (66009-1-Ig, 1:3000) were purchased from Proteintech (Rosemont, IL, USA); p-STAT1 (9167S, 1:1000) and p-P65 (3033S, 1:1000) were purchased from Cell Signaling Technology (Beverly, MA, USA); and STAT1 (A19563, 1:1000) was purchased from ABclonal Technology (WuHan, China).</p></section><section id="sec16"><h3 class="pmc_sec_title">Transwell assay</h3>
<p>T lymphocytes were extracted from the spleen of C57BL/6 mice and seeded into the upper chamber of a Transwell plate (pore size of 8 μm, Corning, NY, USA) with 100 μl of serum-free medium. In the lower chamber, 600 μl of serum-containing medium was added. After 4-hour incubation, the quantity of T cells that traversed from the upper chamber to the lower chamber was analyzed. As T lymphocytes are suspended, they are unable to adhere to the underside of the membrane. We enumerate the cells in lower chamber migrated from the upper chamber using a cell counting device. Three independent experiments were carried out.</p>
<p>For the Transwell assay of Raw264.7 cells, 8 × 10<sup>4</sup> cells were seeded into the upper chamber of a Transwell plate (pore size of 8 μm, Corning, NY, USA) with 100 μl of serum-free medium. After 18 hours, cells that had migrated to the underside of the Transwell membrane were immobilized with 4% paraformaldehyde and, subsequently, stained with crystal violet. Three independent experiments were carried out.</p></section><section id="sec17"><h3 class="pmc_sec_title">In vivo tumor models and treatments</h3>
<p>To establish the subcutaneous tumor model, LLC cells (50× 10<sup>5</sup> cells, 50 μl) were inoculated into the right flank of C57BL/6 mice. When the tumors reached 70 cm<sup>3</sup>, the mice were categorized into five distinct groups and administered various treatment protocols: PBS, S1P@Gel, αPDL1@Gel, free S1P-αPDL1, and S1P-αPDL1@Gel (S1P, 5 μg per mouse; αPDL1, 50 μg per mouse; gel, 50 μl). To establish the tumor recurrence model, most of tumors were surgically removed, leaving about 5% of original tumor masses when the tumors reached 150 cm<sup>3</sup>. Then, the mice were randomly divided into five groups and treated with above treatments. Tumor size was measured every other day with vernier caliper in three dimensions, and body weight was recorded every other day following tumor establishment. Six days after the treatments, the mice were euthanized for different analysis. In this study, tumor burden exceeding 2000 mm<sup>3</sup> or 10% of body weight was considered a mortality endpoint, in accordance with the China’s guideline for humane endpoints in animal experiments (RB/T 173-2018).</p></section><section id="sec18"><h3 class="pmc_sec_title">RNA-seq and analysis</h3>
<p>BMDMs were collected from the femurs and tibias of about 7-week-old C57BL/6 mice and then were cultured in RPMI-1640 medium enriched with 10% FBS and 1% penicillin-streptomycin (Pricella Life Science &amp; Technology Co. Ltd., <a href="https://www.ncbi.nlm.nih.gov/nuccore/PB180120" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PB180120</a>), in the presence of M-CSF (40 ng/ml; Dalian Meilun Biotech Co. Ltd., MA0608) for 7 days. Then, the cells were treated with 1 μM S1P or PBS for 24 hours. Total RNA from BMDMs was extracted using TRIzol (Takara) following the manufacturer’s procedure. RNA samples were sent to Tsingke Biotech for library construction and sequencing. The samples were analyzed by RNA-seq on the MGISEQ-T7 platform.</p></section><section id="sec19"><h3 class="pmc_sec_title">Flow cytometry analysis</h3>
<p>Tumor tissues harvested from mice were cut into small pieces and kept in cold PBS. The tissues were then mechanically processed to obtain a single-cell suspension. These suspensions were treated with RBC lysis buffer (ZUNYAN, Nanjing, China, ZYFB006) to eliminate RBC. To minimize nonspecific binding of antibodies, the cells were incubated with FcR blocking reagent (human, Miltenyi, 130-059-901) for 10 min. Then, the cells that were stained with cell membrane markers were stained with different antibodies for 0.5 hours. To detect the intracellular marks, cells were fixed with formalin and permeabilized with Triton X-100 and then stained with antibodies. The antibodies used in flow cytometry analysis were purchased from BioLegend. The antibodies used for labeling T lymph cells: fluorescein isothiocyanate (FITC)–CD3 (BioLegend, 100204), peridinin-chlorophyll-protein complex (PerCP)–CD45 (BioLegend, 103130), allophycocyanin (APC)–Cy7-CD8 (BioLegend, 100714), PE-Cy7-CD4 (BioLegend, 100422), and APC–IFN-γ (BioLegend, 505810); macrophages: FITC-F4/80 (BioLegend, 123107), PE-CD11b (BioLegend, 101208), and APC-CD80 (BioLegend, 375404); and DCs: APC-Cy7-CD45 (BioLegend, 103116), FITC-CD11C (BioLegend, 117306), PE-CD80 (BioLegend, 104708), and PerCP-CD86 (BioLegend, 105026).</p></section><section id="sec20"><h3 class="pmc_sec_title">Cytokine detection</h3>
<p>Twenty-eight plasma samples of patients with NSCLC and 15 plasma samples of noncancer patients obtained from Shanghai General Hospital were analyzed. The plasma levels of S1P isolated from the 43 patients were detected by an S1P ELISA kit (Shanghai Enzyme-linked Biotechnology, catalog no. ml038623). The serum levels of S1P isolated from mice at 6 days after different treatments were detected by an S1P ELISA kit (Shanghai Enzyme-linked Biotechnology, catalog no. ml062988). To measure the level of cytokines in tumors, the collected tumors were cracked and centrifuged (1500 rpm, 3 min) to obtain the supernatant. The levels of IL-6, TNF-α, and IFN-γ were measured by ELISA kits according to the manufacturer’s instructions.</p></section><section id="sec21"><h3 class="pmc_sec_title">Immunofluorescence staining</h3>
<p>For cell samples, cells were seeded onto confocal dishes and received different treatments. After 24 hours, the cells were fixed by 4% paraformaldehyde for 15 min, followed by permeabilized with 0.1% Triton X-100 for 15 min. The cells were then blocked with 5% bovine serum albumin for 30 min. Separate primary and secondary antibodies were adopted to detect the expression of indicated proteins. 4′,6-Diamidino-2-phenylindole (DAPI; Yeasen Biotech, 40728ES03) was used to stain cellular nucleus. The staining was examined by confocal microscopy. Antibodies used in this study were as follows: CD4 (Abcam plc, ab288724), CD8 (Abcam plc, ab316778), CD80 (Abclonal Biotechnology, A16039), and Ki-67 (Abcam plc, ab15580).</p></section><section id="sec22"><h3 class="pmc_sec_title">Terminal deoxynucleotidyl transferase–mediated dUTP nick end labeling</h3>
<p>The paraffin section was dewaxed and hydrated through a gradient of ethanol solutions to make the cells permeable. The samples were incubated with proteinase K at 37°C for 20 min for cell permeabilization. To label the fragmented DNA chains, the samples were treated with fluorescein-12-dUTP in a humid and dark chamber at 37°C for 60 min. Then, the labeled dUTP was bound with HRP-labeled streptavidin to terminate the reaction. The staining was examined by confocal microscopy.</p></section><section id="sec23"><h3 class="pmc_sec_title">LDH release assay</h3>
<p>BMDMs were treated with either PBS or 1.0 μM S1P for 24 hours. Then, BMDMs were cocultured with LLC cells at radios of 10:1 or 15:1 for another 24 hours. LDH release in supernatants was quantified using a commercial kit (Beyotime, no. C0018S), with controls set for spontaneous release (untreated cells) and maximum release (LLC cells treated with LDH release reagent). The LDH detection reagent was added to the supernatant and incubated for 15 min, followed by absorbance measurement at 450 nm.</p></section><section id="sec24"><h3 class="pmc_sec_title">Immumohistochemical staining</h3>
<p>A total of 97 lung cancer samples obtained from Shanghai General Hospital were collected and constructed into a tissue microarray. The tissue microarray was deparaffinized with xylene and subjected to antigen retrieval using citrate buffer. Goat serum was used to block nonspecific antibody binding. The samples were incubated with S1PR1 antibody (Proteintech, 55133-1-AP; 1:200) overnight, followed by a secondary antibody conjugated with HRP (Proteintech, PR30009; 1:1000) for 2 hours at room temperature. 3,3′-Diaminobenzidine (100 μl) (Proteintech, PR30010) working solution was added and incubated at room temperature for 5 to 10 min. The samples were rinsed with distilled water and counterstained with hematoxylin for 2 to 3 min. The staining intensity, ranging from 0 (negative) to 3 (strong), and the percentage of positive cells, spanning from 0% (0) to 100% (<a href="#R4" class="usa-link" aria-describedby="R4"><em>4</em></a>), with increments at 25, 50, and 75%, were assessed and scored accordingly. The staining score was determined by combining the intensity and the percentage of positive cells.</p></section><section id="sec25"><h3 class="pmc_sec_title">mtROS and mitochondria detection</h3>
<p>Raw264.7 cells were treated with S1P with or without 10 μM Mdivi-1 (Beyotime Biotechnology, SC8028) for 24 hours. After treatment, the cells were stained with 5 μM MitoSOX dye (Beyotime Biotechnology, S0061M) at 37°C for 15 min, followed by wash with PBS. Afterward, the cells were fixed and stained with DAPI (Biotechnology, C1002) and imaged by confocal microscope. For the detection of mitochondria, cells were stained with TMRM (Thermo Fisher Scientific, <a href="https://www.ncbi.nlm.nih.gov/nuccore/I34361" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">I34361</a>), a cell-permeant dye that specifically labels mitochondria, at a concentration that is one-thousandth (1/1000) of its original for 15 min. Then, the cells were washed three times with PBS and imaged by confocal microscope.</p></section><section id="sec26"><h3 class="pmc_sec_title">Biological function of BMDCs</h3>
<p>BMDCs were collected from the femurs and tibias of about 7-week-old C57BL/6 mice and cultured with granulocyte M-CSF (20 ng/ml; Novoprotein, Shanghai, China, CK02) for 5 days and then treated with 0.5 or 1.0 μM S1P or PBS for additional 24 hours. T lymphocytes were isolated from the spleen of OT-I mice and labeled with the CFSE Cell Proliferation Kit (Invitrogen) for 15 min. Then, the CFSE-labeled T lymphocytes were washed with RPMI-1640 medium and then cocultured with the CFSE-labeled T lymphocytes at a ratio of 1:3 for another 72 hours. The proliferation of T cells was detected by flow cytometry.</p></section><section id="sec27"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>All data were presented as means ± SEM and were plotted using GraphPad Prism 9.0. For multiple comparisons, Tukey post hoc tests following one-way analysis of variance (ANOVA) were used, whereas Student’s <em>t</em> test was used for comparisons between two groups. Log-rank (Mantel-Cox) testing was used for survival analysis. The threshold for statistical significance was *<em>P</em> &lt; 0.05, **<em>P</em> &lt; 0.01, ***<em>P</em> &lt; 0.001, and ****<em>P</em> &lt; 0.0001.</p></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p><strong>Funding:</strong> This article was partially supported by the National Research Programs of China (2022YFF0710004 and 2022YFA1206500), the National Natural Science Foundation of China (52450010), the Natural Science Foundation of Jiangsu Province (BK20240040), the postdoctoral Fellowship Program (Grade C) of China Postdoctoral Science Foundation (GZC20231651), the China Postdoctoral Science Foundation Funded Project (2024 M762059), the Suzhou Key Laboratory of Nanotechnology and Biomedicine, the Collaborative Innovation Center of Suzhou Nano Science and Technology, and the 111 Program from the Ministry of Education of China.</p>
<section id="sec28"><p><strong>Author contributions:</strong> Conceptualization: H.S., J.F., Q.C., and X.Z. Methodology: H.S., Q.D., and Q.C. Investigation: H.S., Q.D., Z.C. Q.Z., J.F., Q.C., and X.Z. Data curation: H.S., Z.C. and Q.C. Validation: H.S., Q.Z., and Q.C. Resources: Q.C. Project administration: Q.C. Formal analysis: H.S., Z.C., and Q.C. Visualization: H.S., Q.D., and Q.C. Writing—original draft: H.S., J.F., Q.C., and X.Z. Writing—review and editing: H.S., J.F., and Q.C. Supervision: J.F., Q.C., and X.Z. Funding acquisition: H.S., J.F., and Q.C.</p></section><section id="sec29"><p><strong>Competing interests:</strong> The authors declare that they have no competing interests.</p></section><section id="sec30"><p><strong>Data and materials availability:</strong> All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials.</p></section></section><section id="sec31"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<section id="sec32"><h3 class="pmc_sec_title">This PDF file includes:</h3>
<section class="sm xbox font-sm" id="supplementary-material1"><div class="caption p">
<p>Figs. S1 to S19</p>
<p>Table S1</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333694/bin/sciadv.adw5001_sm.pdf" data-ga-action="click_feat_suppl" class="usa-link">sciadv.adw5001_sm.pdf</a><sup> (5.9MB, pdf) </sup>
</div></div></section></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">REFERENCES AND NOTES</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="R1">
<span class="label">1.</span><cite>Thai A. A., Solomon B. J., Sequist L. V., Gainor J. F., Heist R. S., 
Lung cancer. Lancet
398, 
535–554 (2021).
</cite> [<a href="https://doi.org/10.1016/S0140-6736(21)00312-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34273294/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Lung%20cancer&amp;volume=398&amp;publication_year=2021&amp;pages=535-554&amp;pmid=34273294&amp;doi=10.1016/S0140-6736(21)00312-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R2">
<span class="label">2.</span><cite>Leiter A., Veluswamy R. R., Wisnivesky J. P., 
The global burden of lung cancer: Current status and future trends. Nat. Rev. Clin. Oncol.
20, 
624–639 (2023).
</cite> [<a href="https://doi.org/10.1038/s41571-023-00798-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37479810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Clin.%20Oncol.&amp;title=The%20global%20burden%20of%20lung%20cancer:%20Current%20status%20and%20future%20trends&amp;volume=20&amp;publication_year=2023&amp;pages=624-639&amp;pmid=37479810&amp;doi=10.1038/s41571-023-00798-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R3">
<span class="label">3.</span><cite>Bade B. C., Dela Cruz C. S., 
Lung cancer 2020: Epidemiology, etiology, and prevention. Clin. Chest Med.
41, 
1–24 (2020).
</cite> [<a href="https://doi.org/10.1016/j.ccm.2019.10.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32008623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Chest%20Med.&amp;title=Lung%20cancer%202020:%20Epidemiology,%20etiology,%20and%20prevention&amp;volume=41&amp;publication_year=2020&amp;pages=1-24&amp;pmid=32008623&amp;doi=10.1016/j.ccm.2019.10.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R4">
<span class="label">4.</span><cite>Xu Z., Hao X., Lin L., Li J., Xing P., 
Concurrent chemotherapy and first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first-line treatment in advanced lung adenocarcinoma harboring an EGFR mutation. Thorac. Cancer
12, 
2233–2240 (2021).
</cite> [<a href="https://doi.org/10.1111/1759-7714.14057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8365005/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34180588/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Thorac.%20Cancer&amp;title=Concurrent%20chemotherapy%20and%20first-generation%20epidermal%20growth%20factor%20receptor%20(EGFR)-tyrosine%20kinase%20inhibitors%20(TKIs)%20with%20or%20without%20an%20antiangiogenic%20agent%20as%20first-line%20treatment%20in%20advanced%20lung%20adenocarcinoma%20harboring%20an%20EGFR%20mutation&amp;volume=12&amp;publication_year=2021&amp;pages=2233-2240&amp;pmid=34180588&amp;doi=10.1111/1759-7714.14057&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R5">
<span class="label">5.</span><cite>Kratzer T. B., Bandi P., Freedman N. D., Smith R. A., Travis W. D., Jemal A., Siegel R. L., 
Lung cancer statistics, 2023. Cancer
130, 
1330–1348 (2024).
</cite> [<a href="https://doi.org/10.1002/cncr.35128" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38279776/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Lung%20cancer%20statistics,%202023&amp;volume=130&amp;publication_year=2024&amp;pages=1330-1348&amp;pmid=38279776&amp;doi=10.1002/cncr.35128&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R6">
<span class="label">6.</span><cite>Kato T., Casarini I., Cobo M., Faivre-Finn C., Hegi-Johnson F., Lu S., Özgüroğlu M., Ramalingam S. S., 
Targeted treatment for unresectable EGFR mutation-positive stage III non-small cell lung cancer: Emerging evidence and future perspectives. Lung Cancer
187, 
107414 (2024).
</cite> [<a href="https://doi.org/10.1016/j.lungcan.2023.107414" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38088015/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lung%20Cancer&amp;title=Targeted%20treatment%20for%20unresectable%20EGFR%20mutation-positive%20stage%20III%20non-small%20cell%20lung%20cancer:%20Emerging%20evidence%20and%20future%20perspectives&amp;volume=187&amp;publication_year=2024&amp;pages=107414&amp;pmid=38088015&amp;doi=10.1016/j.lungcan.2023.107414&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R7">
<span class="label">7.</span><cite>Wu J., Lin Z., 
Non-small cell lung cancer targeted therapy: Drugs and mechanisms of drug resistance. Int. J. Mol. Sci.
23, 
15056 (2022).
</cite> [<a href="https://doi.org/10.3390/ijms232315056" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9738331/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36499382/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Non-small%20cell%20lung%20cancer%20targeted%20therapy:%20Drugs%20and%20mechanisms%20of%20drug%20resistance&amp;volume=23&amp;publication_year=2022&amp;pages=15056&amp;pmid=36499382&amp;doi=10.3390/ijms232315056&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R8">
<span class="label">8.</span><cite>Liu A., Wang X., Wang L., Zhuang H., Xiong L., Gan X., Wang Q., Tao G., 
EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR-mutated NSCLC: A network meta-analysis. BMC Cancer
24, 
1390 (2024).
</cite> [<a href="https://doi.org/10.1186/s12885-024-13168-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11555867/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39533233/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=EGFR-TKIs%20or%20EGFR-TKIs%20combination%20treatments%20for%20untreated%20advanced%20EGFR-mutated%20NSCLC:%20A%20network%20meta-analysis&amp;volume=24&amp;publication_year=2024&amp;pages=1390&amp;pmid=39533233&amp;doi=10.1186/s12885-024-13168-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R9">
<span class="label">9.</span><cite>Naimi A., Mohammed R. N., Raji A., Chupradit S., Yumashev A. V., Suksatan W., Shalaby M. N., Thangavelu L., Kamrava S., Shomali N., Sohrabi A. D., Adili A., Noroozi-Aghideh A., Razeghian E., 
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons. Cell Commun. Signal.
20, 
44 (2022).
</cite> [<a href="https://doi.org/10.1186/s12964-022-00854-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8991803/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35392976/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Commun.%20Signal.&amp;title=Tumor%20immunotherapies%20by%20immune%20checkpoint%20inhibitors%20(ICIs);%20the%20pros%20and%20cons&amp;volume=20&amp;publication_year=2022&amp;pages=44&amp;pmid=35392976&amp;doi=10.1186/s12964-022-00854-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R10">
<span class="label">10.</span><cite>Morad G., Helmink B. A., Sharma P., Wargo J. A., 
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell
185, 
576 (2022).
</cite> [<a href="https://doi.org/10.1016/j.cell.2022.01.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35120665/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Hallmarks%20of%20response,%20resistance,%20and%20toxicity%20to%20immune%20checkpoint%20blockade&amp;volume=185&amp;publication_year=2022&amp;pages=576&amp;pmid=35120665&amp;doi=10.1016/j.cell.2022.01.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R11">
<span class="label">11.</span><cite>Ortiz-Muñoz G., Brown M., Carbone C. B., Pechuan-Jorge X., Rouilly V., Lindberg H., Ritter A. T., Raghupathi G., Sun Q., Nicotra T., Mantri S. R., Yang A., Doerr J., Nagarkar D., Darmanis S., Haley B., Mariathasan S., Wang Y., Gomez-Roca C., de Andrea C. E., Spigel D., Wu T., Delamarre L., Schöneberg J., Modrusan Z., Price R., Turley S. J., Mellman I., Moussion C., 
In situ tumour arrays reveal early environmental control of cancer immunity. Nature
618, 
827–833 (2023).
</cite> [<a href="https://doi.org/10.1038/s41586-023-06132-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10284705/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37258670/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=In%20situ%20tumour%20arrays%20reveal%20early%20environmental%20control%20of%20cancer%20immunity&amp;volume=618&amp;publication_year=2023&amp;pages=827-833&amp;pmid=37258670&amp;doi=10.1038/s41586-023-06132-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R12">
<span class="label">12.</span><cite>Zheng S., Wang W., Shen L., Yao Y., Xia W., Ni C., 
Tumor battlefield within inflamed, excluded or desert immune phenotypes: The mechanisms and strategies. Exp. Hematol. Oncol.
13, 
80 (2024).
</cite> [<a href="https://doi.org/10.1186/s40164-024-00543-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11301948/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39107856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp.%20Hematol.%20Oncol.&amp;title=Tumor%20battlefield%20within%20inflamed,%20excluded%20or%20desert%20immune%20phenotypes:%20The%20mechanisms%20and%20strategies&amp;volume=13&amp;publication_year=2024&amp;pages=80&amp;pmid=39107856&amp;doi=10.1186/s40164-024-00543-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R13">
<span class="label">13.</span><cite>Zhang J., Huang D., Saw P. E., Song E., 
Turning cold tumors hot: From molecular mechanisms to clinical applications. Trends Immunol.
43, 
523–545 (2022).
</cite> [<a href="https://doi.org/10.1016/j.it.2022.04.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35624021/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Immunol.&amp;title=Turning%20cold%20tumors%20hot:%20From%20molecular%20mechanisms%20to%20clinical%20applications&amp;volume=43&amp;publication_year=2022&amp;pages=523-545&amp;pmid=35624021&amp;doi=10.1016/j.it.2022.04.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R14">
<span class="label">14.</span><cite>Zhao Y., Shen M., Wu L., Yang H., Yao Y., Yang Q., Du J., Liu L., Li Y., Bai Y., 
Stromal cells in the tumor microenvironment: Accomplices of tumor progression?
Cell Death Dis.
14, 
587 (2023).
</cite> [<a href="https://doi.org/10.1038/s41419-023-06110-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10477351/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37666813/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis.&amp;title=Stromal%20cells%20in%20the%20tumor%20microenvironment:%20Accomplices%20of%20tumor%20progression?&amp;volume=14&amp;publication_year=2023&amp;pages=587&amp;pmid=37666813&amp;doi=10.1038/s41419-023-06110-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R15">
<span class="label">15.</span><cite>Pai S. I., Cesano A., Marincola F. M., 
The paradox of cancer immune exclusion: Immune oncology next frontier. Cancer Treat. Res.
180, 
173–195 (2020).
</cite> [<a href="https://doi.org/10.1007/978-3-030-38862-1_6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7423459/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32215870/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Treat.%20Res.&amp;title=The%20paradox%20of%20cancer%20immune%20exclusion:%20Immune%20oncology%20next%20frontier&amp;volume=180&amp;publication_year=2020&amp;pages=173-195&amp;pmid=32215870&amp;doi=10.1007/978-3-030-38862-1_6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R16">
<span class="label">16.</span><cite>Galassi C., Chan T. A., Vitale I., Galluzzi L., 
The hallmarks of cancer immune evasion. Cancer Cell
42, 
1825–1863 (2024).
</cite> [<a href="https://doi.org/10.1016/j.ccell.2024.09.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39393356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=The%20hallmarks%20of%20cancer%20immune%20evasion&amp;volume=42&amp;publication_year=2024&amp;pages=1825-1863&amp;pmid=39393356&amp;doi=10.1016/j.ccell.2024.09.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R17">
<span class="label">17.</span><cite>Jin S. M., Yoo Y. J., Shin H. S., Kim S., Lee S. N., Lee C. H., Kim H., Kim J. E., Bae Y. S., Hong J., Noh Y. W., Lim Y. T., 
A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion. Nat. Nanotechnol.
18, 
390–402 (2023).
</cite> [<a href="https://doi.org/10.1038/s41565-022-01296-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36635335/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Nanotechnol.&amp;title=A%20nanoadjuvant%20that%20dynamically%20coordinates%20innate%20immune%20stimuli%20activation%20enhances%20cancer%20immunotherapy%20and%20reduces%20immune%20cell%20exhaustion&amp;volume=18&amp;publication_year=2023&amp;pages=390-402&amp;pmid=36635335&amp;doi=10.1038/s41565-022-01296-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R18">
<span class="label">18.</span><cite>Park S., Colville M. J., Paek J. H., Shurer C. R., Singh A., Secor E. J., Sailer C. J., Huang L. T., Kuo J. C., Goudge M. C., Su J., Kim M., DeLisa M. P., Neelamegham S., Lammerding J., Zipfel W. R., Fischbach C., Reesink H. L., Paszek M. J., 
Immunoengineering can overcome the glycocalyx armour of cancer cells. Nat. Mater.
23, 
429–438 (2024).
</cite> [<a href="https://doi.org/10.1038/s41563-024-01808-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11471287/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38361041/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Mater.&amp;title=Immunoengineering%20can%20overcome%20the%20glycocalyx%20armour%20of%20cancer%20cells&amp;volume=23&amp;publication_year=2024&amp;pages=429-438&amp;pmid=38361041&amp;doi=10.1038/s41563-024-01808-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R19">
<span class="label">19.</span><cite>Chen Y., Chen X., Bao W., Liu G., Wei W., Ping Y., 
An oncolytic virus-T cell chimera for cancer immunotherapy. Nat. Biotechnol.
42, 
1876–1887 (2024).
</cite> [<a href="https://doi.org/10.1038/s41587-023-02118-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38336902/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Biotechnol.&amp;title=An%20oncolytic%20virus-T%20cell%20chimera%20for%20cancer%20immunotherapy&amp;volume=42&amp;publication_year=2024&amp;pages=1876-1887&amp;pmid=38336902&amp;doi=10.1038/s41587-023-02118-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R20">
<span class="label">20.</span><cite>Kuo A., Hla T., 
Regulation of cellular and systemic sphingolipid homeostasis. Nat. Rev. Mol. Cell Biol.
25, 
802–821 (2024).
</cite> [<a href="https://doi.org/10.1038/s41580-024-00742-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12034107/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38890457/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Mol.%20Cell%20Biol.&amp;title=Regulation%20of%20cellular%20and%20systemic%20sphingolipid%20homeostasis&amp;volume=25&amp;publication_year=2024&amp;pages=802-821&amp;pmid=38890457&amp;doi=10.1038/s41580-024-00742-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R21">
<span class="label">21.</span><cite>Mohammed S., Bindu A., Viswanathan A., Harikumar K. B., 
Sphingosine 1-phosphate signaling during infection and immunity. Prog. Lipid Res.
92, 
101251 (2023).
</cite> [<a href="https://doi.org/10.1016/j.plipres.2023.101251" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37633365/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Prog.%20Lipid%20Res.&amp;title=Sphingosine%201-phosphate%20signaling%20during%20infection%20and%20immunity&amp;volume=92&amp;publication_year=2023&amp;pages=101251&amp;pmid=37633365&amp;doi=10.1016/j.plipres.2023.101251&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R22">
<span class="label">22.</span><cite>Baeyens A. A. L., Schwab S. R., 
Finding a way out: S1P signaling and immune cell migration. Annu. Rev. Immunol.
38, 
759–784 (2020).
</cite> [<a href="https://doi.org/10.1146/annurev-immunol-081519-083952" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32340572/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu.%20Rev.%20Immunol.&amp;title=Finding%20a%20way%20out:%20S1P%20signaling%20and%20immune%20cell%20migration&amp;volume=38&amp;publication_year=2020&amp;pages=759-784&amp;pmid=32340572&amp;doi=10.1146/annurev-immunol-081519-083952&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R23">
<span class="label">23.</span><cite>Olivera A., Allende M. L., Proia R. L., 
Shaping the landscape: Metabolic regulation of S1P gradients. Biochim. Biophys. Acta
1831, 
193–202 (2013).
</cite> [<a href="https://doi.org/10.1016/j.bbalip.2012.06.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3484219/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22735358/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochim.%20Biophys.%20Acta&amp;title=Shaping%20the%20landscape:%20Metabolic%20regulation%20of%20S1P%20gradients&amp;volume=1831&amp;publication_year=2013&amp;pages=193-202&amp;pmid=22735358&amp;doi=10.1016/j.bbalip.2012.06.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R24">
<span class="label">24.</span><cite>Dixit D., Hallisey V. M., Zhu E. Y., Okuniewska M., Cadwell K., Chipuk J. E., Axelrad J. E., Schwab S. R., 
S1PR1 inhibition induces proapoptotic signaling in T cells and limits humoral responses within lymph nodes. J. Clin. Invest.
134, 
e174984 (2024).
</cite> [<a href="https://doi.org/10.1172/JCI174984" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10869180/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38194271/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Invest.&amp;title=S1PR1%20inhibition%20induces%20proapoptotic%20signaling%20in%20T%20cells%20and%20limits%20humoral%20responses%20within%20lymph%20nodes&amp;volume=134&amp;publication_year=2024&amp;pages=e174984&amp;pmid=38194271&amp;doi=10.1172/JCI174984&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R25">
<span class="label">25.</span><cite>Burg N., Salmon J. E., Hla T., 
Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases. Nat. Rev. Rheumatol.
18, 
335–351 (2022).
</cite> [<a href="https://doi.org/10.1038/s41584-022-00784-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9641499/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35508810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Rheumatol.&amp;title=Sphingosine%201-phosphate%20receptor-targeted%20therapeutics%20in%20rheumatic%20diseases&amp;volume=18&amp;publication_year=2022&amp;pages=335-351&amp;pmid=35508810&amp;doi=10.1038/s41584-022-00784-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R26">
<span class="label">26.</span><cite>Matloubian M., Lo C. G., Cinamon G., Lesneski M. J., Xu Y., Brinkmann V., Allende M. L., Proia R. L., Cyster J. G., 
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature
427, 
355–360 (2004).
</cite> [<a href="https://doi.org/10.1038/nature02284" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14737169/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Lymphocyte%20egress%20from%20thymus%20and%20peripheral%20lymphoid%20organs%20is%20dependent%20on%20S1P%20receptor%201&amp;volume=427&amp;publication_year=2004&amp;pages=355-360&amp;pmid=14737169&amp;doi=10.1038/nature02284&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R27">
<span class="label">27.</span><cite>Mendoza A., Fang V., Chen C., Serasinghe M., Verma A., Muller J., Chaluvadi V. S., Dustin M. L., Hla T., Elemento O., Chipuk J. E., Schwab S. R., 
Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells. Nature
546, 
158–161 (2017).
</cite> [<a href="https://doi.org/10.1038/nature22352" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5683179/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28538737/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Lymphatic%20endothelial%20S1P%20promotes%20mitochondrial%20function%20and%20survival%20in%20naive%20T%20cells&amp;volume=546&amp;publication_year=2017&amp;pages=158-161&amp;pmid=28538737&amp;doi=10.1038/nature22352&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R28">
<span class="label">28.</span><cite>Ran G. H., Lin Y. Q., Tian L., Zhang T., Yan D. M., Yu J. H., Deng Y. C., 
Natural killer cell homing and trafficking in tissues and tumors: From biology to application. Signal Transduct. Target. Ther.
7, 
205 (2022).
</cite> [<a href="https://doi.org/10.1038/s41392-022-01058-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9243142/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35768424/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Signal%20Transduct.%20Target.%20Ther.&amp;title=Natural%20killer%20cell%20homing%20and%20trafficking%20in%20tissues%20and%20tumors:%20From%20biology%20to%20application&amp;volume=7&amp;publication_year=2022&amp;pages=205&amp;pmid=35768424&amp;doi=10.1038/s41392-022-01058-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R29">
<span class="label">29.</span><cite>McGinley M. P., Cohen J. A., 
Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions. Lancet
398, 
1184–1194 (2021).
</cite> [<a href="https://doi.org/10.1016/S0140-6736(21)00244-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34175020/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Sphingosine%201-phosphate%20receptor%20modulators%20in%20multiple%20sclerosis%20and%20other%20conditions&amp;volume=398&amp;publication_year=2021&amp;pages=1184-1194&amp;pmid=34175020&amp;doi=10.1016/S0140-6736(21)00244-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R30">
<span class="label">30.</span><cite>Sun G., Wang B., Wu X., Cheng J., Ye J., Wang C., Zhu H., Liu X., 
How do sphingosine-1-phosphate affect immune cells to resolve inflammation?
Front. Immunol.
15, 
1362459 (2024).
</cite> [<a href="https://doi.org/10.3389/fimmu.2024.1362459" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10932966/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38482014/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Immunol.&amp;title=How%20do%20sphingosine-1-phosphate%20affect%20immune%20cells%20to%20resolve%20inflammation?&amp;volume=15&amp;publication_year=2024&amp;pages=1362459&amp;pmid=38482014&amp;doi=10.3389/fimmu.2024.1362459&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R31">
<span class="label">31.</span><cite>Chongsathidkiet P., Jackson C., Koyama S., Loebel F., Cui X., Farber S. H., Woroniecka K., Elsamadicy A. A., Dechant C. A., Kemeny H. R., Sanchez-Perez L., Cheema T. A., Souders N. C., Herndon J. E., Coumans J. V., Everitt J. I., Nahed B. V., Sampson J. H., Gunn M. D., Martuza R. L., Dranoff G., Curry W. T., Fecci P. E., 
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors. Nat. Med.
24, 
1459–1468 (2018).
</cite> [<a href="https://doi.org/10.1038/s41591-018-0135-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6129206/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30104766/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Med.&amp;title=Sequestration%20of%20T%20cells%20in%20bone%20marrow%20in%20the%20setting%20of%20glioblastoma%20and%20other%20intracranial%20tumors&amp;volume=24&amp;publication_year=2018&amp;pages=1459-1468&amp;pmid=30104766&amp;doi=10.1038/s41591-018-0135-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R32">
<span class="label">32.</span><cite>Duan Y., Leong N. C. P., Zhao J., Zhang Y., Nguyen D. T., Ha H. T. T., Wang N., Xia R., Xu Z., Ma Z., Qian Y., Yin H., Zhu X., Zhang A., Guo C., Xia Y., Nguyen L. N., He Y., 
Structural basis of Sphingosine-1-phosphate transport via human SPNS2. Cell Res.
34, 
177–180 (2024).
</cite> [<a href="https://doi.org/10.1038/s41422-023-00913-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10837145/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38123825/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Res.&amp;title=Structural%20basis%20of%20Sphingosine-1-phosphate%20transport%20via%20human%20SPNS2&amp;volume=34&amp;publication_year=2024&amp;pages=177-180&amp;pmid=38123825&amp;doi=10.1038/s41422-023-00913-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R33">
<span class="label">33.</span><cite>Zhao T., Ding T., Sun Z., Shao X., Li S., Lu H., Yuan J. H., Guo Z., 
SPHK1/S1P/S1PR pathway promotes the progression of peritoneal fibrosis by mesothelial-mesenchymal transition. FASEB J.
38, 
e23417 (2024).
</cite> [<a href="https://doi.org/10.1096/fj.202301323R" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38226856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20J.&amp;title=SPHK1/S1P/S1PR%20pathway%20promotes%20the%20progression%20of%20peritoneal%20fibrosis%20by%20mesothelial-mesenchymal%20transition&amp;volume=38&amp;publication_year=2024&amp;pages=e23417&amp;pmid=38226856&amp;doi=10.1096/fj.202301323R&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R34">
<span class="label">34.</span><cite>Győrffy B., 
Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br. J. Pharmacol.
181, 
362–374 (2024).
</cite> [<a href="https://doi.org/10.1111/bph.16257" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37783508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Pharmacol.&amp;title=Transcriptome-level%20discovery%20of%20survival-associated%20biomarkers%20and%20therapy%20targets%20in%20non-small-cell%20lung%20cancer&amp;volume=181&amp;publication_year=2024&amp;pages=362-374&amp;pmid=37783508&amp;doi=10.1111/bph.16257&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R35">
<span class="label">35.</span><cite>Qin J., Liu J., Wei Z., Li X., Chen Z., Li J., Zheng W., Liu H., Xu S., Yong T., Zhao B., Gou S., Ju S., Teng G. J., Yang X., Gan L., 
Targeted intervention in nerve-cancer crosstalk enhances pancreatic cancer chemotherapy. Nat. Nanotechnol.
20, 
311–324 (2025).
</cite> [<a href="https://doi.org/10.1038/s41565-024-01803-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39496914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Nanotechnol.&amp;title=Targeted%20intervention%20in%20nerve-cancer%20crosstalk%20enhances%20pancreatic%20cancer%20chemotherapy&amp;volume=20&amp;publication_year=2025&amp;pages=311-324&amp;pmid=39496914&amp;doi=10.1038/s41565-024-01803-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R36">
<span class="label">36.</span><cite>Xia T., Fu S., Yang R., Yang K., Lei W., Yang Y., Zhang Q., Zhao Y., Yu J., Yu L., Zhang T., 
Advances in the study of macrophage polarization in inflammatory immune skin diseases. J. Inflamm.
20, 
33 (2023).</cite> [<a href="https://doi.org/10.1186/s12950-023-00360-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10568804/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37828492/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Inflamm.&amp;title=Advances%20in%20the%20study%20of%20macrophage%20polarization%20in%20inflammatory%20immune%20skin%20diseases&amp;volume=20&amp;publication_year=2023&amp;pages=33&amp;pmid=37828492&amp;doi=10.1186/s12950-023-00360-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R37">
<span class="label">37.</span><cite>Chen S., Saeed A., Liu Q., Jiang Q., Xu H., Xiao G. G., Rao L., Duo Y., 
Macrophages in immunoregulation and therapeutics. Signal Transduct. Target. Ther.
8, 
207 (2023).
</cite> [<a href="https://doi.org/10.1038/s41392-023-01452-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10200802/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37211559/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Signal%20Transduct.%20Target.%20Ther.&amp;title=Macrophages%20in%20immunoregulation%20and%20therapeutics&amp;volume=8&amp;publication_year=2023&amp;pages=207&amp;pmid=37211559&amp;doi=10.1038/s41392-023-01452-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R38">
<span class="label">38.</span><cite>Zhang J., Liu X., Wan C., Liu Y., Wang Y., Meng C., Zhang Y., Jiang C., 
NLRP3 inflammasome mediates M1 macrophage polarization and IL-1β production in inflammatory root resorption. J. Clin. Periodontol.
47, 
451–460 (2020).
</cite> [<a href="https://doi.org/10.1111/jcpe.13258" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31976565/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Periodontol.&amp;title=NLRP3%20inflammasome%20mediates%20M1%20macrophage%20polarization%20and%20IL-1%CE%B2%20production%20in%20inflammatory%20root%20resorption&amp;volume=47&amp;publication_year=2020&amp;pages=451-460&amp;pmid=31976565&amp;doi=10.1111/jcpe.13258&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R39">
<span class="label">39.</span><cite>Hou Y., Wang Q., Han B., Chen Y., Qiao X., Wang L., 
CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys. Cell Death Dis.
12, 
523 (2021).
</cite> [<a href="https://doi.org/10.1038/s41419-021-03813-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8140121/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34021126/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis.&amp;title=CD36%20promotes%20NLRP3%20inflammasome%20activation%20via%20the%20mtROS%20pathway%20in%20renal%20tubular%20epithelial%20cells%20of%20diabetic%20kidneys&amp;volume=12&amp;publication_year=2021&amp;pages=523&amp;pmid=34021126&amp;doi=10.1038/s41419-021-03813-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R40">
<span class="label">40.</span><cite>Shah R., Ibis B., Kashyap M., Boussiotis V. A., 
The role of ROS in tumor infiltrating immune cells and cancer immunotherapy. Metabolism
151, 
155747 (2024).
</cite> [<a href="https://doi.org/10.1016/j.metabol.2023.155747" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10872310/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38042522/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Metabolism&amp;title=The%20role%20of%20ROS%20in%20tumor%20infiltrating%20immune%20cells%20and%20cancer%20immunotherapy&amp;volume=151&amp;publication_year=2024&amp;pages=155747&amp;pmid=38042522&amp;doi=10.1016/j.metabol.2023.155747&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R41">
<span class="label">41.</span><cite>Kim D. Y., Lim S. G., Suk K., Lee W. H., 
Mitochondrial dysfunction regulates the JAK-STAT pathway via LKB1-mediated AMPK activation ER-stress-independent <em>manner</em>. Biochem. Cell Biol.
98, 
137–144 (2020).
</cite> [<a href="https://doi.org/10.1139/bcb-2019-0088" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31071273/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.%20Cell%20Biol.&amp;title=Mitochondrial%20dysfunction%20regulates%20the%20JAK-STAT%20pathway%20via%20LKB1-mediated%20AMPK%20activation%20ER-stress-independent%20manner&amp;volume=98&amp;publication_year=2020&amp;pages=137-144&amp;pmid=31071273&amp;doi=10.1139/bcb-2019-0088&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R42">
<span class="label">42.</span><cite>Dai W., Wang G., Chwa J., Oh M. E., Abeywardana T., Yang Y., Wang Q. A., Jiang L., 
Mitochondrial division inhibitor (mdivi-1) decreases oxidative metabolism in cancer. Br. J. Cancer
122, 
1288–1297 (2020).
</cite> [<a href="https://doi.org/10.1038/s41416-020-0778-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7188673/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32147668/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Cancer&amp;title=Mitochondrial%20division%20inhibitor%20(mdivi-1)%20decreases%20oxidative%20metabolism%20in%20cancer&amp;volume=122&amp;publication_year=2020&amp;pages=1288-1297&amp;pmid=32147668&amp;doi=10.1038/s41416-020-0778-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R43">
<span class="label">43.</span><cite>Little A. C., Kovalenko I., Goo L. E., Hong H. S., Kerk S. A., Yates J. A., Purohit V., Lombard D. B., Merajver S. D., Lyssiotis C. A., 
High-content fluorescence imaging with the metabolic flux assay reveals insights into mitochondrial properties and functions. Commun. Biol.
3, 
271 (2020).
</cite> [<a href="https://doi.org/10.1038/s42003-020-0988-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7260371/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32472013/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Commun.%20Biol.&amp;title=High-content%20fluorescence%20imaging%20with%20the%20metabolic%20flux%20assay%20reveals%20insights%20into%20mitochondrial%20properties%20and%20functions&amp;volume=3&amp;publication_year=2020&amp;pages=271&amp;pmid=32472013&amp;doi=10.1038/s42003-020-0988-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R44">
<span class="label">44.</span><cite>Floryk D., Houstĕk J., 
Tetramethyl rhodamine methyl ester (TMRM) is suitable for cytofluorometric measurements of mitochondrial membrane potential in cells treated with digitonin. Biosci. Rep.
19, 
27–34 (1999).
</cite> [<a href="https://doi.org/10.1023/a:1020193906974" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10379904/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biosci.%20Rep.&amp;title=Tetramethyl%20rhodamine%20methyl%20ester%20(TMRM)%20is%20suitable%20for%20cytofluorometric%20measurements%20of%20mitochondrial%20membrane%20potential%20in%20cells%20treated%20with%20digitonin&amp;volume=19&amp;publication_year=1999&amp;pages=27-34&amp;pmid=10379904&amp;doi=10.1023/a:1020193906974&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R45">
<span class="label">45.</span><cite>Ji D., Park J. M., Oh M. S., Nguyen T. L., Shin H., Kim J. S., Kim D., Park H. S., Kim J., 
Superstrong, superstiff, and conductive alginate hydrogels. Nat. Commun.
13, 
3019 (2022).
</cite> [<a href="https://doi.org/10.1038/s41467-022-30691-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9156673/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35641519/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=Superstrong,%20superstiff,%20and%20conductive%20alginate%20hydrogels&amp;volume=13&amp;publication_year=2022&amp;pages=3019&amp;pmid=35641519&amp;doi=10.1038/s41467-022-30691-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R46">
<span class="label">46.</span><cite>Choi S. W., Guan W., Chung K., 
Basic principles of hydrogel-based tissue transformation technologies and their applications. Cell
184, 
4115–4136 (2021).
</cite> [<a href="https://doi.org/10.1016/j.cell.2021.07.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8372535/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34358468/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Basic%20principles%20of%20hydrogel-based%20tissue%20transformation%20technologies%20and%20their%20applications&amp;volume=184&amp;publication_year=2021&amp;pages=4115-4136&amp;pmid=34358468&amp;doi=10.1016/j.cell.2021.07.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R47">
<span class="label">47.</span><cite>Luca A. C., Kurnaeva M., John D. K., Machtinger M., Vollmer N. H. J., Mödl B., Hannich J. T., Eckhard M., Lam H. S., Musiejovsky L., Trenk C., Homolya M., Fürnsinn C., Sombke A., Schabbauer G., Eferl R., Sharif O., Casanova E., Moll H. P., 
Loss of SPHK1 fuels inflammation to drive KRAS-mutated lung adenocarcinoma. Cancer Lett.
623, 
217733 (2025).
</cite> [<a href="https://doi.org/10.1016/j.canlet.2025.217733" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40254091/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Lett.&amp;title=Loss%20of%20SPHK1%20fuels%20inflammation%20to%20drive%20KRAS-mutated%20lung%20adenocarcinoma&amp;volume=623&amp;publication_year=2025&amp;pages=217733&amp;pmid=40254091&amp;doi=10.1016/j.canlet.2025.217733&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R48">
<span class="label">48.</span><cite>Chen Q., Wang C., Zhang X., Chen G., Hu Q., Li H., Wang J., Wen D., Zhang Y., Lu Y., Yang G., Jiang C., Wang J., Dotti G., Gu Z., 
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment. Nat. Nanotechnol.
14, 
89–97 (2019).
</cite> [<a href="https://doi.org/10.1038/s41565-018-0319-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30531990/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Nanotechnol.&amp;title=In%20situ%20sprayed%20bioresponsive%20immunotherapeutic%20gel%20for%20post-surgical%20cancer%20treatment&amp;volume=14&amp;publication_year=2019&amp;pages=89-97&amp;pmid=30531990&amp;doi=10.1038/s41565-018-0319-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<p>Figs. S1 to S19</p>
<p>Table S1</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12333694/bin/sciadv.adw5001_sm.pdf" data-ga-action="click_feat_suppl" class="usa-link">sciadv.adw5001_sm.pdf</a><sup> (5.9MB, pdf) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Science Advances are provided here courtesy of <strong>American Association for the Advancement of Science</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1126/sciadv.adw5001"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/sciadv.adw5001.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (14.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12333694/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12333694/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12333694%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12333694/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12333694/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12333694/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40779634/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12333694/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40779634/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12333694/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12333694/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="Y0o4gaCO5QhiWukhTEPH99b5Rwk0WNCScLs9S8scsfTcKK9XQ2TMOXOZSMXUeKQ6">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
